Podcasts about advancements

Stay informed on current events, visit www.NaturalNews.com - Qatar Energy's Force Majeure and Global Gas Supply Disruption (0:10) - Impact on Aluminum Production and Shipping (2:21) - Iranian Missile Attacks and Media Censorship (4:06) - Economic Implications of the War on Iran (8:40) - Geopolitical Contagion and Economic Leverage (19:12) - Trump's Loss in the War on Iran (22:23) - The Role of AI in the Workforce (1:07:11) - The Economic Doom Loop (1:15:47) - The Role of AI in Business and Personal Life (1:17:47) - Cloud Code and AI Setup (1:21:47) - Advancements in AI and Neural Networks (1:24:09) - Comparison to Human Brain and AI Scalability (1:25:02) - Geopolitics and Technological Leadership (1:27:21) - Open Source Models and Ethical Considerations (1:31:02) - Impact on Education and Job Market (1:33:25) - Covid-19 and Logical Fallacies (1:35:00) - AI Adoption and Workforce Changes (1:37:24) - Survival Supplies and Preparedness (1:39:03) - Final Thoughts and Call to Action (1:41:45) Watch more independent videos at http://www.brighteon.com/channel/hrreport  ▶️ Support our mission by shopping at the Health Ranger Store - https://www.healthrangerstore.com ▶️ Check out exclusive deals and special offers at https://rangerdeals.com ▶️ Sign up for our newsletter to stay informed: https://www.naturalnews.com/Readerregistration.html Watch more exclusive videos here:

Discover why heavy-duty bubble wrap might be the smartest investment for your business. Experts explore puncture resistance, barrier technology, and how advanced materials reduce damage while supporting sustainability. Plus, learn about the surprising environmental benefits of premium packaging solutions.Info: https://www.globepackaging.co.uk/protection/bubble-wrap/jiffy-premium-straight-tear-bubble-wrap.html Globe Packaging City: Hayes Address: Unit 5, Caxton Trading Estate Website: https://www.globepackaging.co.uk/

Steve and Jeff interviewed Erin Hanson, the CEO of Guardian Sports. Hanson discussed the first-ever football helmet chinstrap specifically engineered for impact absorption from facemask blows. The guys also congratulated Will Clapp on a successful NFL career.

In this podcast, business consultant Tavershima Ayede explains how to handle vague client feedback. Many professionals get excited when a prospect says, "It's all good," but Tavershima warns that this phrase often leads to "ghosting" rather than a signed contract.The Strategy: Use "Advancements"Instead of walking away and hoping for the best, you should take control of the meeting using two specific methods: * Propose the Next Step: Don't leave the meeting without a concrete date or action item on the calendar. * Ask Clarifying Questions: Push for honesty. Ask the client directly if they are ready to move forward or if they have lingering hesitations.The Bottom LineBy defining the path forward during the initial conversation, you stop deals from stalling and ensure you aren't left waiting for a call that never comes. If you're struggling to close, Tavershima offers personalized coaching to help keep your pipeline moving.

Join us for an engaging conversation with Jessica Williams, a solutions architect at Sphero, as she shares insights into educational technology, AI integration, and her experiences at conferences. Discover how robotics and AI are transforming K-12 education and get behind-the-scenes stories from the world of edtech. Join us for a lively discussion on winter Olympics ideas, tech gadgets, and humorous anecdotes. Our guests share insights on innovative sports concepts, wearable tech, and funny stories from travel and family life. AI integration in education Sphero's role in STEM learning Conference experiences and insights Ideas for new winter Olympic sports Advancements in wearable technology like the Aura Ring and Google Glass Humorous stories from travel, family, and everyday life  

In this episode of 'Conversations in Lung Cancer Research,' A/Prof Mel Moore talks with Prof Michael Millward, Foundation Professor of Clinical Cancer Research at the University of Western Australia and the oncology Medical Director at Linear Clinical Research in Perth. They discuss Prof Millward's extensive background in clinical and research interests in lung cancer and melanoma, the evolution of clinical trials, and the future of medical oncology, touching on molecular diagnostics, liquid biopsies, and early phase drug development. Millward also shares personal anecdotes and practical advice for young oncologists seeking to integrate clinical research into their careers.(00:00) Introduction and Acknowledgements(00:31) Guest Introduction: Professor Michael Millward(01:49) Early Career and Training(05:23) Specialisation in Oncology(08:15) Advancements in Molecular Oncology(15:03) Building a Phase One Unit(21:37) Mentorship and Future of Clinical Trials(28:23) Future of Lung Cancer Treatment(30:33) Closing Remarks and Final Thoughts 

Episode #194: In this episode, Kimberly Lovi interviews Stephanie Luciano Novo about Epidermolysis Bullosa (EB), a rare genetic skin disease. They discuss the impact of EB on children and families, Stephanie's personal connection to the cause, and the community's efforts to raise awareness and funds for research. The conversation highlights the advancements in treatments and the importance of community involvement in fundraising events like the plunge. The episode emphasizes the urgency of finding a cure and the inspiring resilience of those affected by EB. Chapters 00:00 Introduction to Epidermolysis Bullosa (EB) 06:06 Personal Connection to EB and Community Involvement 12:08 Understanding the Impact of EB on Families 18:03 The Role of Fundraising and Community Events 23:57 Advancements in EB Research and Treatments 29:54 Call to Action and Community Engagement Follow Kimberly on IG: @kimberlylovi EBRB (EB Research Partnership) https://www.instagram.com/ebresearch/     Matter of Time Film https://www.instagram.com/matteroftimefilm/   Matt Finlin - Director of Matter of Time https://www.instagram.com/mattfinlin/   Eddie Vedder, Pearl Jam frontman, is a co-founder of EBRP  https://www.instagram.com/eddievedder/   Jill Vedder - ChairWoman at the EB Research Partnership https://www.instagram.com/jill.vedder/   The official Plunge For Eoldie - Plunge for EB account https://www.instagram.com/plungeforelodie/  

In the final episode of AI360, Head of Applied AI at Deloitte, Jim Rowan, and Rohan Gupta reflect on recent breakthroughs in AI and what's next, including how companies can ensure success with AI.

Stay informed on current events, visit www.NaturalNews.com - Cartel Violence in Mexico: Initial Reports and Context (0:10) - Weapons Trafficking and US Involvement (4:58) - Potential US Military Intervention and Broader Implications (16:11) - Interview with Dan Dix: Real-Time Reporting from Puerto Vallarta (22:55) - Interview with Aaron Day: Personal Experience and Observations (1:01:05) - Broader Implications and Potential Responses (1:01:59) - Mexico's Cartel Problem and International Influences (1:02:55) - Ambassador Huckabee's Controversial Interview (1:25:16) - Historical and Theological Context of Zionism (1:32:50) - Arab States' Reactions and US-Israel Relations (1:35:24) - The Role of Zionism in US Politics (1:45:51) - The Anti-Zionist Position of Torah Jews (1:49:35) - The Impact of Zionism on Global Relations (1:53:03) - Glyphosate Detoxification Strategies (1:55:41) - The Role of Sulfur in Detoxification (2:36:32) - The Future of Battery Technology (2:37:15) - Introduction to Mike Adams and His Background (2:51:02) - Historical Breakthroughs in Science and Technology (2:52:47) - The Role of Energy in Modern Economies (2:54:18) - Challenges and Potential of Grid Shifting Technology (3:00:09) - Environmental and Economic Implications of Donut Lab Battery (3:14:36) - Potential for Off-Grid Living and Energy Independence (3:15:57) - Impact on Transportation and Aviation (3:25:43) - Advancements in AI and Machine Cognition (3:28:46) - Decentralization and Privacy in AI (3:31:27) - Revolutionizing Video Content Creation (3:44:33) - Conclusion and Future Outlook (3:55:36) Watch more independent videos at http://www.brighteon.com/channel/hrreport  ▶️ Support our mission by shopping at the Health Ranger Store - https://www.healthrangerstore.com ▶️ Check out exclusive deals and special offers at https://rangerdeals.com ▶️ Sign up for our newsletter to stay informed: https://www.naturalnews.com/Readerregistration.html Watch more exclusive videos here:

Rapid diagnostics continue to play a critical role in global healthcare, and Wondfo USA focuses on expanding access to fast, reliable testing across clinical, consumer, and public health environments. The company develops point‑of‑care solutions designed to deliver accurate results within minutes, supporting early detection, timely treatment, and improved decision‑making. As healthcare systems worldwide shift toward decentralized testing, rapid diagnostics have become essential tools for both professionals and individuals seeking immediate insight into their health.Wondfo's portfolio spans multiple categories, including infectious disease screening, fertility and hormone monitoring, chronic condition management, and general wellness. These solutions are designed to be easy to use, portable, and accessible, allowing testing to occur in clinics, pharmacies, workplaces, and homes. The company's approach reflects a broader movement toward empowering individuals with actionable information without requiring complex laboratory infrastructure.Technology Designed for Speed and AccuracyThe foundation of Wondfo's diagnostic platform is built on rapid biochemical detection methods that convert biological markers into clear, readable results. These technologies are engineered to maintain high sensitivity and specificity while reducing the time required for analysis. The goal is to provide results that are both fast and trustworthy, supporting confident decision‑making in situations where timing is critical.Advancements in sensor design, reagent stability, and microfluidic control have enabled the company to expand the range of conditions that can be screened outside traditional laboratory settings. As global health demands continue to evolve, rapid diagnostics are increasingly relied upon for early identification of emerging illnesses, routine monitoring of chronic conditions, and support for reproductive health planning.Meeting Global Healthcare NeedsWondfo's solutions are used in diverse regions with varying levels of healthcare infrastructure. In areas where access to laboratories is limited, rapid testing provides a practical alternative that can significantly improve health outcomes. In more developed markets, these tools support convenience, speed, and patient‑centered care by reducing the need for appointments and long wait times.The company's global reach is supported by partnerships with healthcare providers, distributors, and public health organizations. These collaborations help ensure that diagnostic tools are available where they are needed most, whether for routine screening, emergency response, or community‑based health initiatives. The ability to scale production and adapt to changing health demands has positioned rapid diagnostics as a vital component of modern healthcare systems.Consumer Wellness and At‑Home InsightBeyond clinical environments, Wondfo develops consumer‑friendly testing solutions that allow individuals to monitor key aspects of their health at home. These products support fertility planning, hormone tracking, and general wellness monitoring. As consumers increasingly seek personalized insight into their health, at‑home diagnostics provide a convenient and private way to stay informed.The rise of digital health platforms has further expanded the value of rapid testing. When combined with mobile applications, test results can be tracked over time, shared with healthcare providers, or integrated into broader wellness programs. This connection between diagnostics and digital insight supports more proactive and informed health management.ConclusionWondfo USA advances global access to rapid diagnostics through technologies designed for speed, accuracy, and ease of use. By supporting point‑of‑care testing in clinics, pharmacies, workplaces, and homes, the company helps individuals and healthcare providers make timely, informed decisions. As demand for decentralized healthcare continues to grow, rapid diagnostics remain essential tools for improving outcomes, expanding access, and supporting a more responsive and patient‑centered approach to health.Interview by Don Baine, The Gadget Professor.Sponsored by: Get $5 to protect your credit card information online with Privacy. Amazon Prime gives you more than just free shipping. Get free music, TV shows, movies, videogames and more. Secure your connection and unlock a faster, safer internet by signing up for PureVPN today.

Rapid diagnostics continue to play a critical role in global healthcare, and Wondfo USA focuses on expanding access to fast, reliable testing across clinical, consumer, and public health environments. The company develops point‑of‑care solutions designed to deliver accurate results within minutes, supporting early detection, timely treatment, and improved decision‑making. As healthcare systems worldwide shift toward decentralized testing, rapid diagnostics have become essential tools for both professionals and individuals seeking immediate insight into their health.Wondfo's portfolio spans multiple categories, including infectious disease screening, fertility and hormone monitoring, chronic condition management, and general wellness. These solutions are designed to be easy to use, portable, and accessible, allowing testing to occur in clinics, pharmacies, workplaces, and homes. The company's approach reflects a broader movement toward empowering individuals with actionable information without requiring complex laboratory infrastructure.Technology Designed for Speed and AccuracyThe foundation of Wondfo's diagnostic platform is built on rapid biochemical detection methods that convert biological markers into clear, readable results. These technologies are engineered to maintain high sensitivity and specificity while reducing the time required for analysis. The goal is to provide results that are both fast and trustworthy, supporting confident decision‑making in situations where timing is critical.Advancements in sensor design, reagent stability, and microfluidic control have enabled the company to expand the range of conditions that can be screened outside traditional laboratory settings. As global health demands continue to evolve, rapid diagnostics are increasingly relied upon for early identification of emerging illnesses, routine monitoring of chronic conditions, and support for reproductive health planning.Meeting Global Healthcare NeedsWondfo's solutions are used in diverse regions with varying levels of healthcare infrastructure. In areas where access to laboratories is limited, rapid testing provides a practical alternative that can significantly improve health outcomes. In more developed markets, these tools support convenience, speed, and patient‑centered care by reducing the need for appointments and long wait times.The company's global reach is supported by partnerships with healthcare providers, distributors, and public health organizations. These collaborations help ensure that diagnostic tools are available where they are needed most, whether for routine screening, emergency response, or community‑based health initiatives. The ability to scale production and adapt to changing health demands has positioned rapid diagnostics as a vital component of modern healthcare systems.Consumer Wellness and At‑Home InsightBeyond clinical environments, Wondfo develops consumer‑friendly testing solutions that allow individuals to monitor key aspects of their health at home. These products support fertility planning, hormone tracking, and general wellness monitoring. As consumers increasingly seek personalized insight into their health, at‑home diagnostics provide a convenient and private way to stay informed.The rise of digital health platforms has further expanded the value of rapid testing. When combined with mobile applications, test results can be tracked over time, shared with healthcare providers, or integrated into broader wellness programs. This connection between diagnostics and digital insight supports more proactive and informed health management.ConclusionWondfo USA advances global access to rapid diagnostics through technologies designed for speed, accuracy, and ease of use. By supporting point‑of‑care testing in clinics, pharmacies, workplaces, and homes, the company helps individuals and healthcare providers make timely, informed decisions. As demand for decentralized healthcare continues to grow, rapid diagnostics remain essential tools for improving outcomes, expanding access, and supporting a more responsive and patient‑centered approach to health.Interview by Don Baine, The Gadget Professor.Sponsored by: Get $5 to protect your credit card information online with Privacy. Amazon Prime gives you more than just free shipping. Get free music, TV shows, movies, videogames and more. Secure your connection and unlock a faster, safer internet by signing up for PureVPN today.

Dr. Stuart Grant, founder of Archetype Medtech, shares his journey designing and delivering breakthrough orthopedic and surgical innovations across the UK, US, and China. Stuart recounts how an early internship led him into medtech, what kept him there, and how building the ASPAC Innovation Center in China helped accelerate a total knee instrument system that dramatically reduced time to market. He explains the leap from corporate leader to entrepreneur: planning for years, earning a PhD in Medtech Product Innovation, and building a consultancy that helps startups and scale-ups turn early clinical unmet needs into market-ready, regulator-approved devices through a network of experts and an “expertise for equity” model.    Guest links: https://archetype-medtech.com/  Charity supported: Sleep in Heavenly Peace Interested in being a guest on the show or have feedback to share? Email us at theleadingdifference@velentium.com.  PRODUCTION CREDITS Host & Editor: Lindsey Dinneen Producer: Velentium Medical   EPISODE TRANSCRIPT Episode 074 - Stuart Grant [00:00:00] Lindsey Dinneen: Hi, I'm Lindsey and I'm talking with MedTech industry leaders on how they change lives for a better world. [00:00:09] Diane Bouis: The inventions and technologies are fascinating and so are the people who work with them. [00:00:15] Frank Jaskulke: There was a period of time where I realized, fundamentally, my job was to go hang out with really smart people that are saving lives and then do work that would help them save more lives. [00:00:28] Diane Bouis: I got into the business to save lives and it is incredibly motivating to work with people who are in that same business, saving or improving lives. [00:00:38] Duane Mancini: What better industry than where I get to wake up every day and just save people's lives. [00:00:42] Lindsey Dinneen: These are extraordinary people doing extraordinary work, and this is The Leading Difference. Hello, and welcome back to another episode of the Leading Difference podcast. I'm your host Lindsey, and today I'm delighted to welcome Dr. Stuart Grant. Dr. Grant is a chartered engineer and the founder of Archetype Medtech, a consultancy and innovation studio helping medical device startups and scale ups transform early clinical, unmet needs into market ready products. With nearly 25 years of experience, Stuart has led global teams across the UK, US, China, and emerging markets delivering breakthrough innovations in hip, knee, shoulder, and trauma surgery. A highlight of his career was establishing the ASPAC Innovation Center in China, where he built R&D capability from the ground up and launched a pioneering total knee instrument system that dramatically reduced time to market. Passionate about advancing medical technology and mentoring future engineers, he bridges creativity, engineering, and regulation to accelerate safer, smarter medtech innovation worldwide. All right. Welcome to the show. It's so great to have you here today. Thanks for joining me. [00:01:57] Stuart Grant: It's lovely to be here, Lindsey. [00:01:58] Lindsey Dinneen: Yeah. Excellent. Well, I was wondering if you could start by sharing a little bit about yourself, your background, and what led you to medtech. [00:02:08] Stuart Grant: Yeah. So, I was actually, I'm obviously, as you can tell from my accent, I'm British, but I was born in Germany because my, my dad was in the military in the 1970s when I was born. So I was born actually in Berlin, which is quite interesting to be a place to be, grew up in. So I traveled around a lot here in the UK, in Germany with my dad getting posted everywhere. My mom's a nurse. So I was in medtech, not really knowing I was in medtech as a kid, but I, my family was, so yeah. And then obviously went to school, all the places I was at university. I went to university to do product design, and my goal was to be a product designer, a cool product designer, designing fancy products like Johnny Ive. And when I was looking for a job as a co-op, or an intern as you call them in the US, I was just really unsuccessful finding a job. I was doing a lot of interviews, getting turned down, sending my CV out a lot, and j happened just to advertise on the Board of University, and it said Johnson Orthopedics and no one really knew what that was in. And none of my fellow students at applied because they thought it would be designing baby bottles for putting talcum powder in and shampoo in and stuff like that. So they're like, "I'm not doing that job." So I desperately applied for it and luckily found out about all this medtech, and I've been here doing medtech for 25 years. So they gave me a job. I had to work hard to keep the job and get reemployed over and over again. But yeah, joining originally Johnson Orthopedics a long time ago is how I found out about medtech. I never knew when I was 18 that really it was a thing that existed. [00:03:47] Lindsey Dinneen: Yeah. So, okay. So you thought product design, and then when you got into medtech, what were some of the things that attracted you and that actually compelled you to stay and make a career out of it? [00:04:00] Stuart Grant: Ha. So I was a young guy with the student debts. What compelled me, I was getting paid to stay, but not to be too flippant about it, but, you know, when I was doing this engineering and design work in my early days in the CAD system, it was just so interesting. I was designing these products that were going into people or the instrumentation to make help the surgeon and going to these ORs and watching the surgeon do their job and trying to figure out how how I can make it better from their input was really interesting. I could apply it straight away, basically. In the early two thousands, there wasn't all these regulations and standards that slowed you down. So you could go and design an instrument, get it machined in the machine shop, get it clean, take it to the surgeon, he can use it, you know, probably be frowned upon 25 years later. But that's what we used to do and really adapt. And probably more interesting than going into product design and fast moving consumer goods where you're designing a, a kettle or a toaster or something, a plastic casing. It was actually much more interesting to do that. And I stayed because I spent four years here in Leeds, in the UK, was getting a bit bored and wanted to find something else to do, and then an opportunity came up in the US. So I moved over to Warsaw, Indiana, the orthopedics capital of the world, as you might know it. Worked there for, stayed there for seven years. Really enjoyed it.. People sort of bemoan Warsaw for being in the sticks in just a bunch of cornfields around it. But I enjoyed it. It's got, we had a good bunch of young friends there. I was in late twenties, early thirties at the time. There was Noah and Spikes. You'd go for a drink and some nice food. It was all right. I enjoyed my time and after that I was, after seven years, I was like, "Okay, what do I do next?" And I was looking around for jobs in medtech. Then another opportunity came up in and we were looking for people to go over and help set it up, train the staff on what MedTech product development was. And so I jumped to the chance and spent five years living in China, in Shanghai. After five years is your limit, so I had to come home. I couldn't stay. I wanted to stay, but they wouldn't allow me to. So, so I came back to the UK. And then started MDR for five years as leading the Joints MDR program, which was lots of fun, as you could probably tell, wasn't really R&D, was a lot of leadership and project management and dealing with a lot of people and a lot of problems on a day-to-day basis. And so, yeah, after that I I left J&J about three years ago and started my own product development agency. And we can talk about a little bit about that later. So that's where I am and where I got to. [00:06:50] Lindsey Dinneen: Excellent. Yeah, I definitely wanna talk about that as well. But going back a little bit-- and perhaps this is actually something that's occurred since you started your own company as well-- but are there any moments that really stand out to you along your journey of affirming that, "Hey, yeah, I actually am in the right place, in the right industry?" [00:07:12] Stuart Grant: That's a really hard one is sort of the, is the grass always greener somewhere else, type of question. Right? I guess compare, you shouldn't compare, but comparing to my friends at my university, my product design and what they've done and what I've done they've moved into the car industry a lot. Went to the car development and car industries always had its ups and downs and its problems. And you know, they've had some really cracking jobs working for McLaren and Ferrari and you know, but I think just the interesting things that medtech do that nobody really knows about is really what keeps me moving along and having conversations with people when they, you tell them like, "I used to design hips and knees and shoulders and things like that," and they're like, "Oh, my mother's got a hip and knee" and blah, blah, and you really talk about it. Actually, my mother does have a hip now and she's going in a couple months time to get the other hip done. I do know what brand she's got, so. [00:08:10] Lindsey Dinneen: See, that's really cool. Yeah. Okay. So, so, on your LinkedIn I noticed that you describe yourself as a fixer, a challenger, and a change maker, which I love. But I'd love to hear from you exactly what you mean by all those things as you have developed in your career, and now as you're doing, of course, your own consulting. [00:08:34] Stuart Grant: Yeah, so in Johnson and my colleagues are probably, I agree with this, I had a bit of a reputation of getting the more difficult projects. The, that's probably why I got MDR in the end 'cause I would always get the projects that had problems and I enjoyed that. I liked digging deep and solving the problem and wrangling everyone together and pushing everybody along to help. And that was actually one of the reasons why I moved to the US 'cause the original project I moved to was the project leader left and it was in a bit of a shambles. So I went over to sort of, sort of try and get it together and just ended up staying and working on multiple projects. So I like that. Really challenging, not just the engineering side. The engineering side is obviously really interesting, but the challenging project management and people management and process management in a big corporation, all of those things, people, product, process, all come together just to cause a big headache sometimes, you know, herding cats as say and going, trying to solve those problems as an engineer, always trying to solve these problems, right? So it's you're always trying to figure out how you can move forward. [00:09:52] Lindsey Dinneen: Yeah. Yeah, absolutely. So, okay, so that kind of brings us to the company. So what was it like going from employee to entrepreneur? Were you, did you feel ready and prepared for that leap? Or what has that transition and pathway been for you? [00:10:10] Stuart Grant: So I've, I was a long-term planner. I was planning for this for five years whilst I was working for Johnson. So I went and got, when I came back to the UK I started my PhD and I knew getting a PhD was a real way of building credibility immediately, right? Before you step in a room and have a conversation with you, if you've got a PhD in the subject you're about to talk about, people pay attention, hopefully. Right? So I did my, so I did my PhD in Medtech Product Innovation, what the process is. So I spent seven years part-time working for Johnson, getting my PhD, knowing that eventually in my mid forties, there'll be an inflection point, which usually isn't people in big corporations, right, that either stay to the end for until you're six, mid sixties. If you hit 50, usually stay for the next decade, right? Or you leave and do something else. And I was like, "Okay, 45, I'm gonna pull the bandaid, go in, get my PhD, set up my own company plan, get the plan to do it, get the savings," and so I was working on MDR and a new MDR was coming to an end, and then they'd have to find me a new project, which probably didn't exist. So I also knew that J&J would be like, "Ah, Stuart, you've been here for 23 years. There's not really anything of your level here." I'd be like, "Great, let's go." So this was all a, you always it's a big step, right? I have a family. I can't just sort of walk in, not come in the office anymore. So it was a big plan that my wife and I had for quite a number of years to execute. So it's still a struggle. I've been doing it for three years. It's still hard work, still building the company, finding clients, understanding what their pain points are and improving your picture and all those other things, still is still a challenge, but it's a new challenge. [00:12:06] Lindsey Dinneen: Yeah. [00:12:07] Stuart Grant: And as I say, as I said, when people worry about the risk, it's like I can easily just go and get a corporate job again as a move back and have all this new relevant experience. So it's a risk, but you have to balance that by the benefits. [00:12:21] Lindsey Dinneen: Yeah, calculated risk that you've planned for, so good for you. So, okay, so tell us a little bit about your company now and who you help and kind of where in the development or even ideation process that you can come in and really make a difference. [00:12:40] Stuart Grant: So, yeah, so Archetype MedTech is a product development, product innovation agency. And what we do, we usually work with startups or scale ups. Startup side, they'll have a proof of concept. They've already defined the unmet clinical need. They've sort of wrangled the technology and validated the actual technology does what it they're trying to make it do, but they just dunno how to make this a medical device product, right? They've they've got the technology, but they dunno how the product make a product that's sellable is releasable and it gets approved by FDA or here in the, i'll say here in the EU, I know I said in the UK, but MDR and I help them work out that product innovation strategy. So take them all through either they need to do the frontend innovation and understand their needs and the insights and the business case, and then the engineering requirements and specifications. The design and engineering part I help them with, and this is not just me. I have a network of experts, a sort of consortium of experts that come together and bring all these different specialties and then we help them with the testing, what testing they need to do, their risk management, usability, all that fun stuff. And then contact and help them work with the manufacturers. So contract manufacturers, then their regulatory approval. So really what we try to do is, 'cause we're bringing all this expertise as a group of people together, the entrepreneur, usually a salesman or surgeon at this point, who may be a university spin out, can spend a lot of time and money trying to find these experts, trying to find these resources, trying to understand the product development, the MedTech product development process, which is all written down in various books, but when you get down to the details, it gets really complicated. So what we do is help them go through that as fast and as efficiently as a possible, so they're not wasting capital fishing around for those experts. We already have that network of experts that we can bring in and take them through the process as quickly as possible. So that's what Archetype Medtech do for our clients. And has been successful. We have quite a number of clients, mostly in orthopedics and surgical 'cause that's my specialty in medtech. And what we also do, we just don't want to be a management consultancy firm. Well, we do if it's right, we share what we call expertise for equity. So we'll take some equity from the company, but we'll cut our day rates or maybe do it for free, do and help them go through the process as quickly as possible. That means we've got skin in the game, right? We're not just taking their money and going, "Great. This is great. Good luck on the commercialization. Not our problem." [00:15:29] Lindsey Dinneen: Right. [00:15:30] Stuart Grant: It is our problem. 'cause we want a return on our risk and our investment as well. So, yeah, that's what we try to do. And along with that we do a load of pro bono work with surgeons in the NHS who have had ideas. We help them just get their idea a bit further along so they can start looking for funding and investment, and I can share that with you later 'cause it's a really important program that the NHS run it. If there's any mentors out there that want to get involved I can point them in the right direction. [00:16:00] Lindsey Dinneen: Actually that's fantastic and I would love to hear a little bit more about the organization and yeah, how people can get involved and help and what do they all do. [00:16:10] Stuart Grant: Yeah. So the NHS have set up this called NHS Clinical Entrepreneurs Program. This is not my company. This is a completely separate organization. And what it is, clinicians, anybody who works in the NHS-- you know NHS is a 1.6 million people who are employed in the NHS. It's a massive company organization. They come up with clinical needs 'cause they're in the problem and they start working out how they solve it, even through medical device or health tech or an app or anything, right? And they can go into this, it is basically the equivalent of an accelerator program over about nine months. And we have mentors like myself who work with those clinicians to help them develop their idea. So I've got a couple of clinicians that I work with. One is developing a neurosurgical device for helping him cut out tumors in the brain. At the moment, they use two tools. They use a scalpel and a cordy, a bipolar cordy, and they're very basic tools. And what he has to do, he's under a microscope, and he has to swap these one by one, does this scalpel to cut the vascularization of the tumor. Then he has to seal it. And he has to pass the nurse has to pass in these tools and he can't see a, see the nurse passing him. So he is like, "Can I develop a tool that's in one a scalpel and a bipolar" so he doesn't have to keep changing the tool in his hand? And you can know by the cognitive load and changing that tool in the field that these surgeries take eight to 12 hours to cut out a tumor from the brain. So he's saying every, he swaps his tool about 200 times and it takes three seconds. So you can start doing the maths. [00:17:59] Lindsey Dinneen: Yeah. [00:18:01] Stuart Grant: Yeah. And then the other, so the other is a doctor, actually, the doc is a neonatal doctor and he's trying to develop a langoscope for neonatal babies. The langoscopes at the moment haven't really improved in the last 60 years. The Muller blades, they're called, and they're the stainless steel things that basically adult ones have been shrunk down to baby size and changed a little bit. They're not very good. And when you've got a newborn baby who's struggling to breathe, the mother's there obviously upset, so the father's probably there and you're trying to get langoscope down their throat, it's not a great, it is a very stressful situation, so he's kind of developed a, trying to develop a better one, right? Even the simple things. These things are made of stainless steel and you put a piece of metal on a baby's tongue. A newborn baby's obviously never experienced cold before, so they obviously start freaking out and squirming and you're trying to get this thing down her throat. It's crazy. So I'm helping him to see if he can come up with a better solution. He's got a, got an idea at the moment. He's developed some prototypes and we're gonna help him get it, see if we can get it a bit further along, and hopefully get to the market and solve this real small unmet clinical need, but really important one. [00:19:16] Lindsey Dinneen: Yeah. That's incredible to hear about both of those stories. That is really exciting. I love I-- this is partly why I love this industry so much is the innovation coming out of it is always amazing. People care so deeply about making a difference and improving patient outcomes, and then to hear about those kinds of innovations, ugh, that's awesome. [00:19:38] Stuart Grant: Yeah. Yeah. So if there's any experts out there listening who wanna get involved in the N-H-S-C-E-P program, I know Australia does one too. So yeah, get involved and share your knowledge freely to some clinicians who wanna, who have found an unmet clinical need and wanna solve it, but don't know how to. [00:19:56] Lindsey Dinneen: Yeah. Love it. That's fantastic. So it, it seems like, you know, from your career trajectory and your continuing education all this time that you are not someone who sits still very well. And I think you mentioned this a little bit in your LinkedIn profile, you like to keep moving. So one of the things that I noticed that you do, and I'd love if you share about it, is you do lectures on the history of innovation. Could you share a little bit about that? [00:20:24] Stuart Grant: Yeah. So. I I really, so I sort of got into reading about innovate. I love reading innovation books, right, nonfiction, innovation books, which I got in about 10 years ago. I read probably one of the first one was "The Idea Factory," which is about Bell Labs. And that was how Bell Labs has invented the telephone system and invented the transistor, won a load of Nobel Prizes. Shockley and Bardine were there. They just had this crazy Medici effect going on in Bell Labs. The Medici effect when you collect everybody together in a small area and they just start bouncing ideas and coming up with some hugely creative solutions. And that comes from Florence when DaVinci and Michelangelo and Raphael were all kicking about Florence and they were all paid for by the Medici family, so this why it's called the Medici. There's a book about it actually called "The Medici Effect." So I started reading all this and started just going backwards in history and getting to the industrial revolution and how the industrial revolution happened. And going further back to these group of men called the Lunar Men who were in Birmingham here in the UK who basically, it was James Watt, who invented the steam engine, Wedgewood, who was the pottery guy. It is Rasmus Darwin, who was Charles Darwin's great-grandfather. Yeah. All these people, they were called the Lunar Man 'cause they met every month in the full moon and discussed ideas and I think probably got drunk. [00:22:00] Lindsey Dinneen: I mean... [00:22:03] Stuart Grant: So yeah, I just love reading it and you know, I love, I'm now a little bit of a brag. As of last month, I'm a fellow of the Institute of Mechanical Engineers, and that is quite prestigious that was created by George Stevenson, and George Stevenson was the guy who created the steam train. [00:22:23] Lindsey Dinneen: Okay. [00:22:23] Stuart Grant: So we took Watts' idea of the steam engine, put it on wheels, figured out how to work. And I love, I just love steam trains and that's very dorky of me, I know. But I love, as a mechanical engineer, just seeing all the bits move and actually seeing them chug around all the noise and the steam. And here where I live in Yorkshire, in the UK, up the road in York is the National Railway Museum, which all the steam trains are at. Darlington is west. George Stevenson had his the original railway, the Darton Stock Railway. So George Stevenson created the Institute of Mechanical Engineers 'cause he was a mechanical engineer and his son created the rocket the first really fast once, Robert Stevenson. So learning all this and then figuring out how, then I went back-- I'm, so this is a long answer to your question-- then I went back went back and like understood why the industrial revolution happened and it was all about the banking system here, how people could get capital. And then the legal system grew up to protect that capital. And then agriculture improved in the UK so people weren't just stuck on farms, subsistence farming. There was enough food being produced to support the population so the population could go and work in factories and obviously James Watt creating the steam power created more power. So people in horses and everybody didn't have to work so hard. And then there was politics involved with the Hugonos, which were the Protestant, the French Protestants came over and they had all, they had the ability to make all these machine parts, 'cause that's our skill. Some of them came to the UK and the others went to Switzerland. And that's where the watch industry in Switzerland created. And then, you know, and then the scientific approach and the enlightenment came in the UK and it all just sort of bubbled up into the industrial revolution and then cascaded through the 19th century and the 20th century in. Here we are in the 21st century. So I just love knowing that whole pathway of somebody said "We need more legal," and then somebody said, "We need more banking" and as startups, right, investment is the king. So it all started 300 years ago with the UK banking system. [00:24:35] Lindsey Dinneen: Fascinating. Oh my goodness. That is so interesting. Yeah. Okay. One other interesting thing I caught from your LinkedIn profile is that you are a painter, but you are an exhibited painter, yes? [00:24:51] Stuart Grant: Yeah, I, well, I try. [00:24:54] Lindsey Dinneen: Okay. [00:24:54] Stuart Grant: So yeah. Obviously I did product design right? And I did product design because at school, I was good at art and I was good at maths and physics. So I was looking around going, "What discipline do those three things fit together?" And it looked like it was product design. I was like, "Okay, I'm half an engineer, half an artist, not good at either." So about 10 years ago I decided to pick up art again. It was, started to go to classes and doing landscapes and actually sadly the industrial decline of Britain's, so the old buildings of the industrial revolution and stuff like that. So I paint that stuff. [00:25:36] Lindsey Dinneen: Oh, that's so cool. [00:25:37] Stuart Grant: Put it into exhibitions and sometimes get rejected, sometimes get accepted, and try and sell a couple so I can at least call myself an artist. [00:25:45] Lindsey Dinneen: There you go. I love it. Yeah. Well, and that creativity and that artistry does, you know, impact your work in general, because I think sometimes having that outlet actually spurs some just creative solutions outside of the box that, you know, might have not come to you immediately if you were just like, you know, head down, really working hard on this project. And then if you could take a step back do you feel that it helps you in that way at all? [00:26:15] Stuart Grant: Yeah. Yeah, it definitely does. Not thinking about work is and just having it percolate in the background and not actually, 'cause it's a very slow deliberate process painting, right? So it does, you just lose hours and hours painting something, which is really nice. Obviously I've got a, I've got a 5-year-old at the moment running around, so I don't do that much painting. I usually just reserve it for when I go to my art class on Wednesday nights 'cause trying to focus is not a thing for a 5-year-old. [00:26:46] Lindsey Dinneen: Yeah, That's fair. Okay. Well, all right, so pivoting the conversation just for fun. Imagine that you were to be offered a million dollars to teach a master class on anything you want. It could be within your industry. It also could be your history of innovation, but what would you choose to teach? [00:27:08] Stuart Grant: So I thought about this when you gave that question because I was like, "Well, I've already talked about the history of innovation and that can pretty boring." So my other boring side, when you do a PhD, you always wish you did another subject. That's the thing is like, I wish I studied that instead. So my, as you go through the PhD, you learn other things and you're like, "Oh, that's really interesting." And you go down rabbit holes and you're like, "Oh, well stop. That's not my job. That's not what I'm trying to do here." One of the ones was how technology and society are interlinked. So technology drives society, and we've got lots of examples of that. Steam engines, trains, telephones, electricity, light bulb, broadband, and now AI. And so technology affects society. Then society drives technology. They're a virtuous circle. Some people say it not virtuous at all, but they, that's what happens. And understanding how those two things, society and culture and technology all interact is really interesting to me. And obviously not all technologies are adopted. Some are abandoned. Sometimes the better technology is abandoned for an inferior technology for lots and lots of reasons. There's examples. In the eighties, it was VHS and beta max, Blu-ray and HD DVDs. And what else? The keyboard, QWERTY keyboard is meant to be terrible. And that was designed 'cause of typewriters at the time. So the keys didn't smash together, but obviously that's not needed anymore. So those things interest me and I like to study that more, but I like to study it. Thinking about medtech and how our technology in medtech has affected society and using that lens 'cause we also always talk about clinical needs, right? What's your unmet clinical need? What are you trying to solve here? But there's also a social and cultural need that you are maybe not addressing directly, but you are addressing it. And how that drives medtech, and you know, it's we talk about like medtech equality and democratizing medtech and making it more accessible, but there's always the flip size of medtech inequalities. The big one probably at the moment is robotic surgery. Hugely expensive. Only available to very few. So how will that filter through society? How does that affect society? Will it just be for the rich developed countries to use robotic surgery? How will that affect it going forward the next 10, 20 years? Because it uses a capital equipment, right? They can't be diffused through society very easily. So that, that's one thing I would like to study and sort of talk about a little bit more, 'cause I think it's really interesting, especially now AI is being talked about and how digitizing healthcare is gonna happen over the next decade. Interesting if we're overclaiming that at the moment and a lot of startups are overclaiming, what they can really do and is it gonna, is there gonna be a backlash? Who knows? Let's see. In our, maybe in a decade, I'll present a course on it. [00:30:23] Lindsey Dinneen: There you go. Okay. And time will tell. Alright. I like it. Very cool. Okay. And how do you wish to be remembered after you leave this world? [00:30:34] Stuart Grant: Yeah. My PhD was like, I would probably like, I'd like to remember my PhD findings, but I'm like, no, who cares? [00:30:44] Lindsey Dinneen: Oh. [00:30:45] Stuart Grant: I, I've got, of course, my family, making an impact on my, what I've done here with my family, but, and I was really thinking about this question earlier. I was like, "Well, I hope this isn't the end. I hope I haven't peaked." [00:31:02] Lindsey Dinneen: Yes, that's fair, okay. [00:31:06] Stuart Grant: So maybe the next 20, 30 years, hopefully I'll be remembered for something, I hope. [00:31:12] Lindsey Dinneen: Okay. To be determined. I like that. I like that a lot all right. [00:31:18] Stuart Grant: It's a positive. [00:31:20] Lindsey Dinneen: Yeah. It's, and it's a forward way of thinking that, you know, you don't have to limit yourself to what you've already done or accomplished or seen. Who knows? The world is exciting. Yeah. I like it. Okay. [00:31:33] Stuart Grant: Well, yes, I'm yeah, definitely. [00:31:35] Lindsey Dinneen: Yeah, all. [00:31:36] Stuart Grant: One of the things we're doing-- I was looking at the Australian MedTech market and really just trying to figure out what's going on to see if there's anything I can do there. And talking to my wife, we decided, 'cause my daughter's not at school yet, we decided, "Let's go to Australia for an extended holiday." And it was gonna be like a month and we'll start working it all out, like we're just gonna go for three months, March, April and May this year, to sort of experience Australia, experience the MedTech market, go meet a lot of people, understand and just sort of grow and try to understand another way of people. I know Australia, they've got a similar culture to the UK and the US. But they do, they are far away. So they have a different take on things. And I wanna see what a difference is and see if I can get involved. So we're off to Australia on the MedTech market, so if anybody's listening, reach out to me on LinkedIn. It'll be we'll hopefully when I'm over there, we are in Brisbane. We can meet up. [00:32:32] Lindsey Dinneen: Excellent. Yeah, no, that's really exciting. And I actually have a few people I can connect you with as well, so, yeah. Okay. And then final question. What is one thing that makes you smile every time you see or think about it? [00:32:48] Stuart Grant: Oh. I think it's, it is back to my old answers, it's back to the steam trains. I just love watching the mechanism going around. My, me and my daughter who's exhibiting engineering characteristics, shall we say. Love, we love going to the railway museum and running around 'cause you can go and touch the trains, you can get on them, you can get your hands greasy if you want to, if you touch the wrong bit of it. She loves seeing them. And they're just, so when these engineers designed all these big bits of metal, they didn't have FEA or CAD or anything. They just sort of took a guess at the curves and how it should look. And some of these parts they designed are so beautiful when you start looking at them, it just makes me smile, like there was a person, a man, we'll have to say a man, right, 'cause it was 200 years ago... [00:33:44] Lindsey Dinneen: Right. [00:33:44] Stuart Grant: A engineer who decided he was gonna make it like that out of wood. And they were cast into iron and they just they were just sitting in their shop and just did what they thought was right. And most of the time it didn't break. [00:34:00] Lindsey Dinneen: Most of the time. There you go. Yeah. That's great. I love that. Well this has really been a fantastic conversation. I'm so grateful for you joining me today and sharing just some of your history and you know, what you're looking forward to next. I think it's, I think it's really incredible when you get to combine all the different things, like you said. You've got sort of that design and problem solving and you've got the engineering and you've got all these cool things that just make you an incredible help to the MedTech industry. And we're excited to be making a donation on your behalf, as a thank you for your time today, to Sleep in Heavenly Peace, which provides beds for children who don't have any in the United States. So thank you for choosing that charity to support. Thanks for joining and thanks for everything you're doing to change lives for a better world. [00:34:52] Stuart Grant: Yeah, thanks, Lindsey. It's been a real pleasure talking to you. [00:34:55] Lindsey Dinneen: Yeah, absolutely. Thank you again. [00:35:00] Dan Purvis: The Leading Difference is brought to you by Velentium Medical. Velentium Medical is a full service CDMO, serving medtech clients worldwide to securely design, manufacture, and test class two and class three medical devices. Velentium Medical's four units include research and development-- pairing electronic and mechanical design, embedded firmware, mobile app development, and cloud systems with the human factor studies and systems engineering necessary to streamline medical device regulatory approval; contract manufacturing-- building medical products at the prototype, clinical, and commercial levels in the US, as well as in low cost regions in 1345 certified and FDA registered Class VII clean rooms; cybersecurity-- generating the 12 cybersecurity design artifacts required for FDA submission; and automated test systems, assuring that every device produced is exactly the same as the device that was approved. Visit VelentiumMedical.com to explore how we can work together to change lives for a better world.

Troy University students earned seventeen awards from this year's Southeastern Journalism Conference. And, Troy's College of Health Sciences has recently made several advancements, including a new research building and a new doctoral program.

Stay informed on current events, visit www.NaturalNews.com - Bright Videos News Introduction and AI Inflection Point (0:10) - BrightVideos.com Platform Overview (1:39) - AI Video Technology and Future Developments (5:23) - Chinese New Year and Gold and Silver Markets (13:02) - Political News and Palantir Hacking Allegations (18:08) - AI Infrastructure and Market Demand (24:46) - Health Ranger Store and Food Testing (31:02) - Dunning Kruger Effect and AI Job Replacement (35:13) - AI's Exponential Growth and Human Replacement (55:06) - AI's Connection to Morphic Fields (1:07:37) - Morphic Fields and AI Intelligence (1:22:07) - Human Cognition and Power Consumption (1:26:36) - AI Efficiency and Future Projections (1:34:01) - Advancements in AI Technology (1:34:21) - Philosophical Implications and AI Capabilities (1:36:59) - Decentralization of Creativity (1:43:49) - Challenges and Opportunities for AI in Media (1:52:37) - Ethical Considerations and Intellectual Property (1:55:34) - The Future of AI in Entertainment (2:11:08) - Impact on Hollywood and the Media Industry (2:23:10) - Hollywood's Fake News and AI's Real Potential (2:23:49) - The Decline of Hollywood and the Rise of AI (2:48:47) - Conservative AI Illiteracy and Job Replacement (2:52:05) - The Role of Religion and Demographics in AI Skepticism (3:07:14) - The Cultural and Educational Barriers to AI Adoption (3:20:39) - The Future of AI and Its Impact on Society (3:36:27) Watch more independent videos at http://www.brighteon.com/channel/hrreport  ▶️ Support our mission by shopping at the Health Ranger Store - https://www.healthrangerstore.com ▶️ Check out exclusive deals and special offers at https://rangerdeals.com ▶️ Sign up for our newsletter to stay informed: https://www.naturalnews.com/Readerregistration.html Watch more exclusive videos here:

Our 235th episode with a summary and discussion of last week's big AI news!Recorded on 01/02/2026Hosted by Andrey Kurenkov and Jeremie HarrisFeel free to email us your questions and feedback at contact@lastweekinai.com and/or hello@gladstone.aiRead out our text newsletter and comment on the podcast at https://lastweekin.ai/In this episode:* Major model launches include Anthropic's Opus 4.6 with a 1M-token context window and “agent teams,” OpenAI's GPT-5.3 Codex and faster Codex Spark via Cerebras, and Google's Gemini 3 Deep Think posting big jumps on ARC-AGI-2 and other STEM benchmarks amid criticism about missing safety documentation.* Generative media advances feature ByteDance's Seedance 2.0 text-to-video with high realism and broad prompting inputs, new image models Seedream 5.0 and Alibaba's Qwen Image 2.0, plus xAI's Grok Imagine API for text/image-to-video.* Open and competitive releases expand with Zhipu's GLM-5, DeepSeek's 1M-token context model, Cursor Composer 1.5, and open-weight Qwen3 Coder Next using hybrid attention aimed at efficient local/agentic coding.* Business updates include ElevenLabs raising $500M at an $11B valuation, Runway raising $315M at a $5.3B valuation, humanoid robotics firm Apptronik raising $935M at a $5.3B valuation, Waymo announcing readiness for high-volume production of its 6th-gen hardware, plus industry drama around Anthropic's Super Bowl ad and departures from xAI.Timestamps:(00:00:10) Intro / Banter(00:02:03) Sponsor Break(00:05:33) Response to listener commentsTools & Apps(00:07:27) Anthropic releases Opus 4.6 with new 'agent teams' | TechCrunch(00:11:28) OpenAI's new GPT-5.3-Codex is 25% faster and goes way beyond coding now - what's new | ZDNET(00:25:30) OpenAI launches new macOS app for agentic coding | TechCrunch(00:26:38) Google Unveils Gemini 3 Deep Think for Science & Engineering | The Tech Buzz(00:31:26) ByteDance's Seedance 2.0 Might be the Best AI Video Generator Yet - TechEBlog(00:35:14) China's ByteDance, Alibaba unveil AI image tools to rival Google's popular Nano Banana | South China Morning Post(00:36:54) DeepSeek boosts AI model with 10-fold token addition as Zhipu AI unveils GLM-5 | South China Morning Post(00:43:11) Cursor launches Composer 1.5 with upgrades for complex tasks(00:44:03) xAI launches Grok Imagine API for text and image to videoApplications & Business(00:45:47) Nvidia-backed AI voice startups ElevenLabs hits $11 billion valuation(00:52:04) AI video startup Runway raises $315M at $5.3B valuation, eyes more capable world models | TechCrunch(00:54:02) Humanoid robot startup Apptronik has now raised $935M at a $5B+ valuation | TechCrunch(00:57:10) Anthropic says 'Claude will remain ad-free,' unlike an unnamed rival | The Verge(01:00:18) Okay, now exactly half of xAI's founding team has left the company | TechCrunch(01:04:03) Waymo's next-gen robotaxi is ready for passengers — and also 'high-volume production' | The VergeProjects & Open Source(01:04:59) Qwen3-Coder-Next: Pushing Small Hybrid Models on Agentic Coding(01:08:38) OpenClaw's AI 'skill' extensions are a security nightmare | The VergeResearch & Advancements(01:10:40) Learning to Reason in 13 Parameters(01:16:01) Reinforcement World Model Learning for LLM-based Agents(01:20:00) Opus 4.6 on Vending-Bench – Not Just a Helpful AssistantPolicy & Safety(01:22:28) METR GPT-5.2(01:26:59) The Hot Mess of AI: How Does Misalignment Scale with Model Intelligence and Task Complexity?See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Send a text

Matthew Shindell contrasts Islamic scientific advancements with European views, highlighting how Dante Alighierireinterpreted Mars in the Divine Comedy as a symbol of fortitude and martyrdom.

Agriculture Secretary Brooke Rollins signed a Memorandum of Understanding that memorializes the relationship between the U.S. Department of Agriculture and the U.S. Department of War.

Thank you to everyone who tuned into my live video! Join me for my next live video in the app.Lots of tech news this year. Time to catch up and wrap up some news you might have missed.TOPICS:0:00 Countdown Music4:50 Cold Open9:40 AI job takeover?29:40 AI blackmails engineers?34:50 Checkout Pickax Social37:00 Unplugged Phone STOPS Hackers?42:00 Reading YOUR Comments1:13:33 Checkout Parler1:24:20 YT Flagged Comment & The One China Policy1:36:00 Faux Closing1:37:30 Justice For Benghazi1:47:00 Real ClosingAcross The Socials @TheAndresSegovia IG: https://www.instagram.com/theandressegovia/X: https://x.com/_AndresSegoviaShow Notes:https://TheAndresSegovia.comSupport The Show!My Amazon Store:https://www.amazon.com/shop/theandressegoviashowThe Goat Farm Skin Care: https://thegoatfarm.idevaffiliate.com/25.htmlBlackout Coffee: https://www.blackoutcoffee.com?p=wC4nmVNoaUse Promo Code THEANDRESSEGOVIA for 20% off your order!Gainful Protein: http://gainful.com/ANDRESSEGOVIABUBS Naturals Wellness Products: https://shop.bubsnaturals.com/TheAndresSegoviaAll Affiliate Links: https://theandressegovia.start.page To hear more, visit theandressegovia.substack.com

We challenge you to follow us as we discuss the cutting edge advancements in A.I. The paid family leave act has already surpassed financial expectations and it is not good. Johnny Heidt with guitar news. Heard On The Show:Driver shot and killed after fleeing deputies in Duluth, sheriff saysDon Lemon hires former federal prosecutor Joe Thompson as attorney in church protest caseShooter in Canada kills 9 people and injures 25 others at a school and homeSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Stay informed on current events, visit www.NaturalNews.com - EPA Deregulation and Netanyahu's Visit to DC (0:10) - John Kiriakou's Whistleblowing and Integrity (1:23) - Ring Doorbell and Surveillance Concerns (6:16) - Netanyahu's Threats to Trump (7:41) - Economic Impact of Trump's Policies (8:40) - Bureau of Labor Statistics Revision (12:06) - EPA's Deregulation and Climate Change (19:23) - China's Advancements in AI and Energy (28:52) - Off-Grid Living and Energy Independence (38:44) - Glyphosate in USDA Organic Foods (47:11) - Introduction and Background of John Kiriakou (58:17) - John Kiriakou's Views on the Trump Administration (58:36) - Middle East Conflict and U.S. National Interest (58:54) - Technological Asymmetry and Economic Implications (1:31:40) - Challenges of U.S. Military Dominance (1:41:35) - Conclusion and Personal Reflections (1:47:22) Watch more independent videos at http://www.brighteon.com/channel/hrreport  ▶️ Support our mission by shopping at the Health Ranger Store - https://www.healthrangerstore.com ▶️ Check out exclusive deals and special offers at https://rangerdeals.com ▶️ Sign up for our newsletter to stay informed: https://www.naturalnews.com/Readerregistration.html Watch more exclusive videos here:

In this episode of the Uplevel Dairy Podcast, Peggy Coffeen sits down with Dr. George Wiggins to discuss his extensive career in dairy cattle genetics and genomics. Dr. Wiggins shares his journey from growing up on a dairy farm to working closely with Dr. Paul Van Radden, leading to significant contributions in genetic evaluations that propel the dairy industry. He highlights the transformative role of genomics in doubling genetic progress and improving dairy cattle productivity. Dr. Wiggins also touches upon his international experiences, including his time with the Peace Corps and the USDA, and reflects on the recognition he received as a Pioneer Award winner from the National Dairy Shrine. Throughout the conversation, the emphasis is on the importance of innovation, data accuracy, and continuous improvement in dairy genetics.00:50 Early Life and Influences01:43 Academic Journey and Mentorship05:01 International Experience and Career Decisions08:59 Return to Academia and USDA Career10:27 Advancements in Dairy Genetics12:39 Impact of Genomics24:43 Future of Dairy Genetics27:46 Recognition and ReflectionsAward applications: https://dairyshrine.org/awards/Scholarship applications: https://dairyshrine.org/youth/#scholarDonate to Dairy Shrine: https://dairyshrine.org/donate/ YouTube channel: https://youtube.com/@dairyshrine?si=dS_EVxaA1XhUXBhzInformation about webinarTopic: “Avoiding Burnout in a 24/7 Industry”Date: February 11, 2026Time: Noon CentralClick here to register: https://us06web.zoom.us/webinar/register/WN_eTGV4PLeTe2gI4np7Lrlzg

As new calcium-modifying technologies expand the repertoire of below-the-knee (BTK) arterial disease interventions, how should your treatment algorithm evolve, and what endpoints matter most? In this episode of the BackTable Podcast, Dr. Constantino Peña of the Baptist Health Miami Cardiac and Vascular Institute joins Dr. Sabeen Dhand to discuss the latest advancements in BTK chronic limb-threatening ischemia (CLTI) therapies and the push to improve on current vessel preparation outcomes. --- This podcast is supported by: Shockwave Medicalhttps://shockwavemedical.com/ --- SYNPOSIS The physicians discuss the evolution of tibial arterial therapies, the challenges presented by heavily calcified lesions, and the impact of new tools, particularly the Shockwave E8 intravascular lithotripsy (IVL) device, on procedural considerations and endpoints. Dr. Peña shares his treatment algorithms and offers practical advice on selecting the right tools for each unique case. The episode closes with speculation on the future of treatment options and technologies for BTK disease, and the growing need for robust data to guide patient-specific treatment. --- TIMESTAMPS 00:00 - Introduction02:11 - Understanding Tibial Disease and Treatment Evolution07:22 - Advancements in Tibial Disease Treatment and the Role of IVL15:31 - Techniques for Effective IVL Sizing and Usage 21:28 - Challenges and Innovations in Tibial Disease Management26:48 - Innovations in Stent Technology30:43 - Combining IVL with Adjunct Therapies32:13 - Addressing Misconceptions in Tibial Treatment37:54 - Advancements in Intravascular Lithotripsy40:59 - Future of Vascular Treatments43:42 - Final Thoughts

In this episode of the PFC Podcast, Dennis and Emily Johnston delve into the critical topic of cold weather medicine, specifically focusing on the newly submitted Cold Weather Clinical Practice Guidelines (CPG) for the Arctic. Emily emphasizes the importance of these guidelines as adjuncts to existing protocols, highlighting the unique challenges posed by extreme cold environments, such as the constant threat of hypothermia and frostbite. She explains how the guidelines are designed to enhance existing trauma care practices by incorporating specific considerations for operating in frigid conditions, ensuring both the caregiver and the casualty are adequately protected and treated.The conversation also touches on practical strategies for managing injuries in cold weather, including the use of tourniquets and the importance of maintaining body heat. Emily shares insights on nutrition for both rescuers and patients in extreme cold, emphasizing the need for high-calorie, easily consumable foods. The episode concludes with a discussion on the latest advancements in frostbite treatment, including the use of ibuprofen and isoprost, and the significance of timely intervention in preserving tissue viability. Overall, this episode serves as a vital resource for medical professionals operating in cold environments, providing them with essential knowledge and tools to improve patient outcomes.TakeawaysHypothermia and frostbite are constant threats in extreme cold.Nutrition is crucial; high-calorie foods are essential for survival.Timely intervention is key in frostbite treatment.Patient packaging must be done carefully to prevent heat loss.Chapters00:00 Introduction to Cold Weather Medicine01:10 Understanding the Need for an Arctic CPG10:14 Nutrition in Extreme Cold Environments27:06 Advancements in Frostbite Treatment35:15 Patient Packaging and Communication in Cold EnvironmentsFor more content go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.prolongedfieldcare.org⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Consider supporting us: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠patreon.com/ProlongedFieldCareCollective⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ or ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.lobocoffeeco.com/product-page/prolonged-field-care

SpaceTime with Stuart Gary Gary - Series 29 Episode 16In this episode of SpaceTime, we dive into groundbreaking revelations about Europa's ice shell, explore new evidence for the existence of a potential Planet Nine, and discuss a significant advancement in quantum physics that challenges the Heisenberg Uncertainty Principle.Europa's Ice Shell Thickness RevealedData from NASA's Juno mission has provided the first insights into the thickness of Europa's icy crust, estimating it to be around 29 kilometers. This measurement comes from Juno's 2022 flyby, where the spacecraft utilized its microwave radiometer to analyze the moon's surface temperature and characteristics. The findings suggest that beneath this thick ice lies a global ocean of liquid water, potentially harboring the ingredients necessary for life. Understanding the ice shell's structure is crucial for future missions, including NASA's Europa Clipper, set to arrive in 2030.The Case for Planet NineA new study published in Nature Astronomy presents fresh simulations suggesting that wide-orbit planets, like the hypothesized Planet Nine, could be a natural outcome of chaotic early planetary systems. Researchers found that during turbulent phases of stellar formation, planets can be flung into distant orbits rather than being ejected entirely. This work offers a 40% chance that a Planet Nine-like object exists, providing a promising avenue for future exploration as telescopes become more capable of surveying the distant solar system.Advancements in Quantum PhysicsIn a remarkable breakthrough, physicists have demonstrated a method to sidestep the Heisenberg Uncertainty Principle, allowing for simultaneous precise measurements of a particle's position and momentum. This innovative approach, detailed in Science Advances, could pave the way for ultra-precise sensor technologies across various fields, including navigation and astronomy. The study redefines the boundaries of quantum measurement, offering new possibilities for scientific exploration.www.spacetimewithstuartgary.com✍️ Episode ReferencesNature AstronomyScience AdvancesBecome a supporter of this podcast: https://www.spreaker.com/podcast/spacetime-your-guide-to-space-astronomy--2458531/support.

Stay informed on current events, visit www.NaturalNews.com - The Great Cratering and Financial Crisis (0:11) - The Song "The Great Cratering" (4:03) - Investment Strategies and Precautions (7:43) - Trump's Economic Views and Reality (12:25) - Concentration Camps and Depopulation Agenda (24:14) - The Role of AI and Bitcoin in the Economic Crisis (47:22) - Preparing for the Economic Collapse (1:12:32) - The Future of AI and Robotics (1:15:04) - The Impact of AI on Decentralization (1:15:26) - The Role of Breakthrough Battery Technology (1:16:57) - Model Breakthrough and Decentralization Technology (1:19:35) - Advancements in AI and Automation (1:25:37) - Interview with Patrick Henningsen on Iran and Middle East Conflict (1:29:18) - Challenges for the US in Attacking Iran (1:42:26) - Geopolitical Implications and Economic Warfare (1:56:35) - The Role of China and Russia in Supporting Iran (1:56:49) - The Future of Global Trade and Commerce (2:06:49) - The Role of Gold and Silver in Economic Stability (2:07:09) - The Impact of US Economic Policies on Allies (2:07:40) - The Future of MAGA and US Politics (2:15:38) Watch more independent videos at http://www.brighteon.com/channel/hrreport  ▶️ Support our mission by shopping at the Health Ranger Store - https://www.healthrangerstore.com ▶️ Check out exclusive deals and special offers at https://rangerdeals.com ▶️ Sign up for our newsletter to stay informed: https://www.naturalnews.com/Readerregistration.html Watch more exclusive videos here:

Our 233rd episode with a summary and discussion of last week's big AI news!Recorded on 01/30/2026Hosted by Andrey Kurenkov and Jeremie HarrisFeel free to email us your questions and feedback at contact@lastweekinai.com and/or hello@gladstone.aiRead out our text newsletter and comment on the podcast at https://lastweekin.ai/In this episode:Google introduces Gemini AI agent in Chrome for advanced browser functionality, including auto-browsing for pro and ultra subscribers.OpenAI releases ChatGPT Translator and Prism, expanding its applications beyond core business to language translation and scientific research assistance.Significant funding rounds and valuations achieved by startups Recursive and New Rofo, focusing on specialized AI chips and optical processors respectively.Political and social issues, including violence in Minnesota, prompt tech leaders in AI like Ade from Anthropic and Jeff Dean from Google to express concerns about the current administration's actions.Timestamps:(00:00:10) Intro / BanterTools & Apps(00:04:09) Google adds Gemini AI-powered ‘auto browse' to Chrome | The Verge(00:07:11) Users flock to open source Moltbot for always-on AI, despite major risks - Ars Technica(00:13:25) Google Brings Genie 3 'World Building' Experiment to AI Ultra Subscribers - CNET(00:16:17) OpenAI's ChatGPT translator challenges Google Translate | The Verge(00:18:27) OpenAI launches Prism, a new AI workspace for scientists | TechCrunchApplications & Business(00:19:49) Exclusive: China gives nod to ByteDance, Alibaba and Tencent to buy Nvidia's H200 chips - sources | Reuters(00:22:55) AI chip startup Ricursive hits $4B valuation 2 months after launch(00:24:38) AI Startup Recursive in Funding Talks at $4 Billion Valuation - Bloomberg(00:27:30) Flapping Airplanes and the promise of research-driven AI | TechCrunch(00:31:54) From invisibility cloaks to AI chips: Neurophos raises $110M to build tiny optical processors for inferencing | TechCrunchProjects & Open Source(00:35:34) Qwen3-Max-Thinking debuts with focus on hard math, code(00:38:26) China's Moonshot releases a new open-source model Kimi K2.5 and a coding agent | TechCrunch(00:46:00) Ai2 launches family of open-source AI developer agents that adapt to any codebase - SiliconANGLE(00:47:46) Tiny startup Arcee AI built a 400B-parameter open source LLM from scratch to best Meta's LlamaResearch & Advancements(00:52:53) Post-LayerNorm Is Back: Stable, ExpressivE, and Deep(00:58:00) [2601.19897] Self-Distillation Enables Continual Learning(01:03:04) [2601.20802] Reinforcement Learning via Self-Distillation(01:05:58) Teaching Models to Teach Themselves: Reasoning at the Edge of LearnabilityPolicy & Safety(01:09:13) Amodei, Hoffman Join Tech Workers Decrying Minnesota Violence - BloombergSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Most AI infrastructure today is hitting a breaking point. Marc Austin, CEO of Hedgehog, reveals how open source networking and cloud-native solutions are revolutionizing how enterprises build and operate AI at scale. This episode addresses issues many building AI infrastructure today are facing — expensive proprietary systems, overwhelming complex network configurations, and ways to make on-prem AI infrastructure feel just like the public cloud.We discuss how networking is the hidden bottleneck in scaling GPU clusters and the surprising physics and hardware innovations enabling higher throughput. Marc shares the journey of building Hedgehog, an open source, cloud-native platform designed for AI workloads that bridges the gap between complex hardware and seamless, user-friendly cloud experiences. Marc explains how Hedgehog's software abstracts and automates the networking complexity, making AI infrastructure accessible to enterprises without dedicated networking teams.We break down the future of AI networks, from multi-cloud and hybrid environments to the rise of Neo Clouds and the open source movement transforming enterprise AI infrastructure. If you're a CTO, data scientist, or AI innovator, understanding these network innovations can be your moat. Listen to this episode to see how open source, cloud-native networking, and physical innovation are shaping the AI infrastructure of tomorrow.Podcast LinksWatch: ⁠⁠⁠⁠https://www.youtube.com/@alexa_griffith⁠⁠⁠⁠Read: ⁠⁠⁠⁠⁠⁠https://alexasinput.substack.com/⁠⁠⁠⁠⁠⁠Listen:⁠⁠ https://creators.spotify.com/pod/profile/alexagriffith/⁠⁠More: ⁠⁠⁠⁠https://linktr.ee/alexagriffith⁠⁠⁠⁠Website: ⁠⁠⁠⁠https://alexagriffith.com/⁠⁠⁠⁠LinkedIn: ⁠⁠⁠⁠https://www.linkedin.com/in/alexa-griffith/⁠⁠⁠⁠Find out more about the guest at LinkedIn:  https://www.linkedin.com/in/austinmarc/Website: https://hedgehog.cloud/Github: https://github.com/githedgehogChapters00:00 Rethinking AI Infrastructure02:49 The Role of Networking in AI05:54 Marc's Journey to Hedgehog08:46 Lessons from Big Companies11:38 Requirements for AI Networks14:48 Advancements in AI Networking17:33 Future Challenges in AI Infrastructure20:46 Creating a Cloud Experience On-Prem23:32 The Shift to Hybrid Multi-Cloud28:10 Evolving AI Infrastructure and Efficiency30:57 AI Workloads and Network Configurations32:41 Zero Touch Lifecycle Management35:12 Support for Hardware Devices35:45 Networking Paradigms and Vendor Lock-in38:42 The Rise of Neo Clouds41:31 Demand for AI Infrastructure43:57 Open Source and Cloud-Native Networking47:27 Challenges of Building a Networking Startup50:46 Proud Accomplishments at Hedgehog52:41 Future Excitement in AI Inference

Chris Duffin sits down with Nicholas Thompson, CEO of The Atlantic, elite masters distance runner, and author of "The Running Ground: A Father, a Son, and the Simplest of Sports." As they dive into Nick's multifaceted journey—from leading award-winning journalistic organizations to breaking running records after 40—you'll hear how the discipline and lessons from athletic pursuits translate directly into personal growth, leadership, and resilience. Throughout their conversation, Chris Duffin and Nick Thompson (speaking on behalf of Nick) explore the intersections of family, career, and performance, drawing parallels between pushing physical limits and professional success. Nick shares candid stories about motivation, self-doubt, parenting, and the unique influence of his father—a journey marked by extraordinary accomplishments and deeply human challenges.  

“Predictive coding offers a powerful lens for understanding psychosis…”Dr. Marta Garrido is a professor at the Melbourne School of Psychological Sciences, where she leads the Cognitive Neuroscience and Computational Psychiatry Laboratory and directs the Cognitive Neuroscience Hub. She is also a research program lead at the Graeme Clark Institute. With a background in engineering physics from the University of Lisbon and a PhD in neuroscience from University College London under the mentorship of Professor Karl Friston, Marta has become a leading figure in understanding how the brain processes predictions and surprise. Her research spans mismatch negativity, predictive coding theory, dynamic causal modeling, and the development of cutting-edge neuroimaging technologies, including Australia's first optically pumped MEG system.In this episode, Peter and Marta explore the elegant framework of predictive coding and its implications for understanding psychiatric conditions like psychosis. They discuss how the brain generates predictions about sensory input and how disruptions in these mechanisms may contribute to symptoms of mental illness. Marta shares her journey from engineering to neuroscience, her transformative PhD experience, and the challenges of building a new MEG system from the ground up. The conversation covers fascinating topics including mismatch negativity as a prediction error signal, subcortical shortcuts for processing threatening stimuli, the phenomenon of blindsight, and the critical importance of mentorship in academic careers. Marta also offers candid reflections on being a woman in neuroscience and her vision for the future of computational psychiatry.We hope you enjoy this episode!Chapters:00:00 - Introduction to Dr. Marta Guerrero04:46 - Journey from Engineering to Neuroscience10:39 - Understanding Predictive Coding and Bayesian Inference18:34 - Implications of Predictive Coding in Schizophrenia27:08 - Advancements in Brain Imaging Techniques36:31 - Exploring Blindsight and Subcortical Shortcuts44:14 - Reverse Engineering the Brain: Challenges and Ambitions51:23 - The Journey of Developing Optically Pumped Magnetometers01:00:29 - Promoting Women in Neuroscience and Leadership ChallengesWorks mentioned:15:59 - Randeniya et al. (2018). Sensory prediction errors in the continuum of psychosis. https://doi.org/10.1016/j.schres.2017.04.01918:36 - Goodwin et al. (2026). Predictive processing accounts of psychosis: Bottom-up or top-down disruptions. https://doi.org/10.1038/s44220-025-00558-526:02 - Larsen et al. (2019). 22q11.2 deletion syndrome: intact prediction but reduced adaptation. https://doi.org/10.1016/j.nicl.2019.10172129:40 - Garvert et al. (2014). Subcortical amygdala pathways enable rapid face processing. https://doi.org/10.1016/j.neuroimage.2014.07.04729:40 - McFadyen et al. (2017). A rapid subcortical amygdala route for faces. https://doi.org/10.1523/JNEUROSCI.3525-16.2017Episode producers:Karthik Sama, Xuqian Michelle Li

  Guest: Bob Zimmerman. Zimmerman analyzes the failing Roscosmos, describing Russia's declining space program and its inability to compete with American and Chinese advancements.1957

Advancements in our understanding of primary biliary cholangitis (PBC) and new therapeutic agents have reshaped the care landscape of PBC. Listen now to learn how these developments are helping to redefine and elevate treatment goals. Topics covered include:How and when to assess treatment responseRisk factors in PBCBiochemical treatment response and fibrosis stage as predictors of transplant-free survivalDynamics of liver stiffness measurements and clinical outcomes in PBCThe importance of bilirubin and alkaline phosphatase normalizationThis episode is the first of 3 recap podcasts, featuring audio from our live satellite symposium, Raising the Bar: Innovations in PBC Care. For the full on-demand webcast of this satellite symposium, and to download the accompanying slides, visit the program page for this episode: https://bit.ly/44ZJ5osPresenters:Christopher L. Bowlus, MDLena Valente Professor and ChiefDivision of Gastroenterology and HepatologySchool of MedicineUniversity of California DavisSacramento, CaliforniaAparna Goel, MDClinical Associate Professor of MedicineDivision of Gastroenterology and HepatologyStanford UniversityPalo Alto, CaliforniaAliya F. Gulamhusein, MD, MPH, FRCPCProfessorship in PSC ResearchClinician Investigator, Toronto General HospitalAssistant Professor, University of TorontoDivision of Gastroenterology and HepatologyUniversity Health NetworkToronto, CanadaGet access to all of our new episodes by subscribing to the Decera Clinical Education Medical Specialties Podcast on Apple Podcasts, YouTube Music, or Spotify.   Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

* Businesses have a huge opportunity by using AI * Remembering JPSO Deputy Ohlmeyer, who was tragically killed last week * Gov. Landry revealed his spending plan. Let's break it down * Nearly 40% of Americans are estranged from a family member. Are you? * Is AI going to take many of our jobs? * Here are some concrete steps to take to save more money this year

Dr. Deb Muth 0:03Welcome back to let’s Talk Wellness. Now, I’m your host, Dr. Deb. If you’re a woman who’s doing everything right, eating clean, exercising, taking supplements, yet you still feel exhausted, inflamed, or like your body suddenly stopped cooperating, this episode is for you. Today’s conversation challenges one of the biggest myths in women’s health. That midlife struggles are just about hormones or worse, just part of aging. My guest today is Dr. Deb Heald, a naturopathic physician with one of the most fascinating backgrounds I’ve ever encountered. Yeah, she’s got a really diverse background, which is kind of exciting. She’s been an ER nurse, a stockbroker, a Silicon Valley data analysis, teaching machines to learn from microbiome research. And yes, she holds an mba, too. But it was her own menopause crash that changed everything. When the protocols she had been teaching stopped working for her, her, she didn’t double down on templates or trends. She did what she was trained to do. She followed the data and what she discovered reframed menopause, metabolism and women’s longevity in a completely different way. This isn’t about willpower. It’s not about another diet, and it’s definitely not about copying what worked for someone else. It’s about learning to listen to your body and finally understanding what it’s been trying to tell you and all along. So grab your cup of coffee or tea, settle in, and let’s dive into this amazing conversation about women’s health and menopause. And right after our guest is arriving with us, we’re going to get a word from our sponsor quick here. And then we are going to come right back to having this conversation with Dr. Deb Heald. Ladies, it’s time to reignite your vitality. Primal Queen supplements are clean, powerful formulas made for women like you who want balance, strength, and energy that lasts. Get 25% off@primal queen.com Serenity Health. Because every queen deserves to feel in her prime. But okay. All right. Welcome back, everybody. I am here with my new friend, Dr. Deb Heald. And she has such an amazing background, like I shared with you a few minutes ago. But I would love for her to give us her insight in how she got where she did, because it’s rare that you find somebody with a data background and a medical background. So, Dr. Dove, welcome. Dr Deb Heald 2:30Thank you. I am so glad to be here, and it’s a real privilege to meet you. Dr. Deb Muth 2:34I feel the same way. Dr Deb Heald 2:35Yeah, it’s. I think that the more of us that start to think and practice this way, the easier it’s going to be for women going forward. Because it’s not easy. Dr. Deb Muth 2:44It is not easy. I mean, I’ve been in this industry a long time, over 25 years. And every time I think it’s getting easy, it’s getting harder for a variety of reasons. It’s the medical system, it’s the. The clients we work with are sicker. It’s taking longer to get them to a place where they feel good. There’s just so many variables these days. So tell me a little bit about what got you here. Dr Deb Heald 3:06Well, I made the decision when I was graduating from high school to be a nurse instead of a teacher, because those were really still the two options that were common for women. I thought about medicine at that point, but my sister convinced me that if I would spend all that time learning and practicing medicine, I might not be as good of a mom. So I took the path of nurse, because nurse works around kids schedules and that sort of thing. I’d only been practicing about six months before I thought, oh my gosh, there has to be more to it than this, and toyed with the idea of starting med school at that point, but then married and started having children, and I just sort of fell into that pattern. But I typically work emergency room. There was a short stent in the post anesthesia recovery room as well. And emergency room was a place where western medicine actually shone. Right. People come in, they are no longer capable of functioning, they’re having a heart attack, they lost limb. Whatever else, they do need the, the bells and the whistles of western medicine. But when you think about it, western medicine was derived out of the Civil War where you didn’t have to say what’s the cause of the problem. It was a bullet or a bayonet, and it was, it was about patching up the soldiers and getting them back on the front line so they could continue to fight. And naturopathic medicine, which had been a lot around for an awful lot longer than that, just didn’t work in the battlefield then. The assessment was done in the early 1900s as to which style of medicine got people back to work faster. The Flexner report was all about how corporations could maximize the value of employees. And naturopathic medicine didn’t win because nutritional fixes take a long time. Taking away somebody’s stress so that they can just function more capably is. It’s a, It’s a big ask, right? So the funding of naturopathic medicine went away and western medicine became all that we knew. So in context to the emergency room, it worked. But when I saw the same person coming in, having their third heart attack, I just thought, how is this happening? Has no one told this person what, what’s going on in their lifestyle that’s creating this environment for them to continue to have heart attacks? And so that’s when I made the switch. And that was after 17 years in practice as a nurse to head on over to the naturopathic side. There was a little bit of a, a segue there, but we’d need a much longer interview to get into the details of that. I was a stock broker for six years. Anyway, when I jumped into the idea of med school, it didn’t make sense to be practicing the same thing that was already being practiced because I saw where it worked and I saw where it was failing. So hopped into the naturopathic tract. I also had one child that had a lot of physical and emotional ailments that western medicine couldn’t solve. Their answer to everything was putting her on amoxicillin. And I, I just absolutely could not convince the medical system that she didn’t have a deficiency of antibiotics, but that was their only solution. And so while she was on the antibiotics, her sinuses were clear, her sleep apnea was not an issue, and she appeared better, but her microbiome got decimated. She was on antibiotics for seven years. So, yeah, so my pursuit down the naturopathic pathway was in large part to try and figure out what else could be done for my daughter. And I did take her to a naturopath or I embarked on the field myself. And her GP threatened to call social services. Oh my gosh, yes. Dr. Deb Muth 6:22You hear these stories, I’ve heard these stories from clients before over really dumb things that they’re going to call CPS for. And it always blows my mind that we think it’s appropriate to call CPS on somebody who’s truly not injuring their child. Dr Deb Heald 6:38So anyway, that started my 17 year path in the naturopathic realm. And after, after I’ve been in practice about 10 years, an opportunity came up to move to Silicon Valley and research the microbiome and then take what we were learning from the microbiome and program it into AI. So I did that for a few years and it was amazing. There was a huge disconnect between the funding model and what its expectations were and what the research was able to do. There was a time gap, there was a funding gap. And so I thought, medicine doesn’t understand what’s important to business. And Business isn’t understanding what’s critical to research. So I went and did my MBA and wanted to be able to be the translator between those two worlds. And then the pandemic hit and then. Dr. Deb Muth 7:24Everyone’S life got turned upside down, right? Dr Deb Heald 7:26Yeah. Yeah. So I’m back in private practice. My, my practice always tended to be more autoimmune focused, which is predominantly women and predominantly middle aged women. But through my own experience of menopause and looking at how I assisted people that were in menopause before I was, you know, that the success rate wasn’t as high as it needed to be. And I started to really drill down into the biochemistry behind what was going on and then also realized that my menopause was very different than even my sister’s menopause. There we were, the same genetic template, the same lived environment, though very different lived experiences in that environment. And realized that we have to find ways to make it relevant to the person in front of us. And it’s not so much which herbs will or won’t work historically, it’s how is this person’s body responding in the immediate term to the diet we’ve put them on, to the nutritional plan we’ve suggested to the supplements, and because we’ve come so far in the data world, our whoop straps or aura rings or whatever else, there’s so many devices that are actually able to let us know whether somebody’s burning carbs or fat in this moment or ketones. We can see how an individual’s body is responding and course correct right now. And it isn’t that a ketogenic diet may not be helpful down the road. It’s right now it’s actually putting more stress on your body than it’s already under, which puts you into fight flight, which stops you from burning fat. So, and it’s not just the burning fat, it’s the inflammation. Right. So our food is completely void of nutrients. And we used to have 24 inches of topsoil, now we’ve got, so who’s eating four times the number of vegetables that we, we used to eat to get the same number of nutrients? We’re just not. And our environment is so full of plastic and chlorine molecules and just toxins that our liver says, I have no idea what that is, I have no idea how to detoxify it. And we can’t, we can’t clean the air around us. We can put air filters in our homes and try not to live under pulp mills. But the world is just becoming a Much more aggressive place to live. Dr. Deb Muth 9:33So it definitely is. I mean from the time that you and I grew up to the time that we have now, we have over 75,000 new chemical in just that short period of time. And honestly, as you and I both know, these chemicals have never been tested for this long term use or the way we’re using it, or how much we’re using them or exposing them to our kids that’s never been tested to see how safe they truly are. Dr Deb Heald 10:01I have to apologize to my children and all of the children of that generation. We use latex baby bottles that were plastic line and we linked them up in the microwave. So the wave of endocrine disruption that’s coming at us from practice feeding our infants plastic, it’s a different world. And so we have to approach it just in a completely different way. And you know, menopause shouldn’t be a disease or a state of dis ease, but it is because we’re so depleted. And women used to have predictable stresses and now because most of us are working outside of the home, many are have children that have, how do I want to put this confounders. The number of kids that are neurodiverse and the, the ext work that that creates in a household is unbelievable. So moms typically carrying most of that and then all the guilt that goes with it because moms do guilt, our nervous systems are completely fry, right? So we’re in a constant state of low level fight flight and it changes every single other biochemical process in our body. So when we hit the hormone depletion of menopause, every organ system is profoundly affected. And then we do see more autoimmune diseases cropping up. We do see more inflammatory conditions turning into organ systems not working. And the medical system is. I don’t, I hate to say this, but it’s decades from being able to figure this out. So in the immediate term, what can we do for every woman out there and, and help surround them with community? That’s the other thing that’s really missing. How often do we go next door and have tea or coffee with our neighbors? Dr. Deb Muth 11:41You don’t anymore? Dr Deb Heald 11:42No. So where’s the community supporting you? Dr. Deb Muth 11:45You don’t have one unless it’s online. And then if it’s online, you know how that goes. You can have some support and you can have not support and you can have people be really rude to you. But that support is not the same as having the neighbor next door that you can call on that you can go over and just get out of your house for a few moments and have somebody truly support you. And, and I think back in the day that’s what women did, women supported women. And today there’s so much competition that women are no longer supporting each other. We’re many times tearing women down and judging them and accusing them of doing things that aren’t right for their career, their family, their husband, their this, their that. It could go any way or any shape, but we’ve stopped supporting women in the decisions that they make, whether it’s to be at home or to work or do both or to not have children or to have children. We were just chatting earlier before we came on about having children late in life. That support is completely gone, at least from what I’ve been seeing and hearing, hearing in my practice and what I’m seeing around me. Dr Deb Heald 12:48So another form of depletion. Right. So right. Deplete. Our, our society is. And it’s a wonder we’re upright at all. And all of the other pressures that we take on. We’ve just come through the holiday season and having to have the holidays just so, so that everybody else thinks we’re doing a good job. So our family is enjoying themselves at the cost of our sanity. And the shame that goes with feeling like you’re not enough. Dr. Deb Muth 13:14Yeah. And for your family and your kids to just be like, I don’. Time to come, I don’t have time to do this. I, I hear this every day. You know, families that women mostly that are creating these beautiful experiences for their kids and their relatives. And then at the last minute you have one that calls and says I can’t come and another one that calls and says I have to go to my in laws or I have to go here, I have to go there. And then again we go back to this guilt of what did I do wrong as a woman, as a mother, to not have everybody be with me for the holidays. And I’ve worked so hard to create this environment, beautiful experience for them, for nobody to care but me. Dr Deb Heald 13:53Yes. Dr. Deb Muth 13:53And then that just depletes us more. Dr Deb Heald 13:55So, and then, and then you hit the, your breaking point and you go see your doctor who first of all doesn’t, doesn’t have the time. And I, I can’t call doctors practicing in the world today because you might be scheduled for 15 minutes, but they’re running late. I, I knew a physician quite well who in the wintertime was so busy in Canada with cold and flus, he’d see a hundred people a day. Yeah. So Sitting in front of him, trying to say, so devastated inside because of this happening or that happening. They, they don’t have or take the time to address what’s really going on there. So the number of times people say to me, you’re the first person that has actually sat and listened to me. Dr. Deb Muth 14:36And yeah, I get that same thing. And that’s, that’s part of what natural medicine is. How do you get to know somebody and understand what’s happening to them if you don’t hear their stories? Dr Deb Heald 14:45Agreed. So it’s, it’s a tricky world for women to navigate, so we have to be here for each other. And where I’m sitting right now in practice is literally just helping women replete themselves and looking at the different organ systems or the organelles within the systems that, that being supplied with what they need. And where do we start with this woman? You know, it’s not everybody that needs to have their GI tract optimized first, though. That’s a pretty common one for a lot of women that feel like they’re going out of their minds. We have to start with brain. But everything we do to, to make the environment better for the brain function also makes everything better for the cardiac function and the muscle function. But it’s, it’s just so misunderstood. And then when we get into the, the metabolism, which is where most women end up coming in, is, why am I gaining weight? Right. And so the weight is the physical manifestation that finally breaks them. But what caused them to be gaining weight is also impacting their brain and their heart and their liver and their, their entire system. It’s just, that’s the thing that finally made them come and get help. But when we look at how metabolism comes to a screeching halt in menopause, it’s a wonder that we can carry on at all. Dr. Deb Muth 16:00Yeah. So at what age do you think women should start paying attention to their situation, to their data, and not just their symptoms? Dr Deb Heald 16:0830 way, way, way before you hit menopause, let’s have a strong baseline. Let’s see what’s happening in your early adult life that is putting you into a state that right now you’ve got the tolerance to fix, but over a longer period of time is going to lead to inflammation and dysfunction. And I’m seeing my nieces actually start to pay attention and my daughter to, to their health in a different way. And I think the wearables have a huge amount to do with that. Right. So if you went out last night and celebrated and you’re paying any Attention to a recovery score. And you see that that fourth tequila took three days for you to recover from. Maybe next time don’t have four. Yeah, right. Dr. Deb Muth 16:58One or two, Right? Yeah. Dr Deb Heald 17:00Yeah. Lack of sleep. How does that actually impact you? For how many days? Something that is not. Not the best choice, though. If you’re eating well, 80% of the time, you’re way ahead of the curve. But when you. When you eat something that upsets your system, you can know that right now, literally, if you’re watching heart rate and you eat something that’s inflammatory to you, your heart rate will go up by six or seven beats a minute almost immediately. And that’s a little thing saying your immune system just kicked in. Is this the right thing for you to eat? So the. The more people pay attention without obsessing, and especially on the food thing, I don’t want to create disordered eating for people, but getting to know your body, getting to know its tolerance, and then as women start to have children, how did those tolerances change? Well, they’ll change profoundly because your sleep just disappeared. Yeah, right. If nothing. Dr. Deb Muth 17:54And your hormones changed and everything else is different. And I think that’s a really great point about the wearables. Like, people can get really obsessed with that data, but I don’t think people really understand how to use the data appropriately. You know, like, if you’re eating something that you don’t normally eat or you’re eating something that you know is somewhat inflammatory, you know, it’s the holidays. I’m gonna have some chips. I’m gonna have, you know, some cheese. I’m gonna have some nuts. I’m gonna have a variety of things. That’s really where you want to check your data, right? You know, your. You’re doing something that’s outside of the norm. And we all kind of know, like, I’m puffier, I’m swollen, my brain’s a little foggy. Maybe I have more pain. That’s the time you really want to tune in and say what’s happening? And then start tracking that. Draw the line so that, you know, like, this is the food that bothers me. Because sometimes it can be a healthy food. It doesn’t always have to be a bad food. You know, it can be a healthy food. I have patients that are allergic to lettuce, and they wonder why they’re gaining weight when they’re dieting, and all they’re doing is eating salad. Salads, and you find out they have an allergy to lettuce, and they take that out and their weight goes right back to normal. So it doesn’t have to necessarily always be a bad thing. But using that data appropriately could really make a huge difference. Dr Deb Heald 19:07And making informed choices. Dr. Deb Muth 19:08Yeah. Dr Deb Heald 19:09I was born with a dairy allergy. One of the proteins in milk. And so, and gosh, in the, in the early 60s there weren’t options for formulas that weren’t dairy based. So I was raised on evaporated milk because the heating process in evaporating the, the fluid out of the milk broke down this particular protein. So how I don’t have diabetes, I do not know. But I will elect sometimes to eat Manchego cheese and I know that tomorrow I’m going to pay for it. But I’m making an informed decision today to do it or I’m making an informed decision today. Not. Yeah, right. And so giving people the power, I think the data is power when you know how to use it. And so when women have pregnancies later in their reproductive cycle, seeing how fast that pregnancy taxation on hormones and then the, when the pregnancy concludes and the hormones fall through the floor, I have seen so many women whose ovaries never recover, they start perimenopause literally in that postpartum period. And so knowing that and making sure that you are getting, you know, the sleep that you need, making sleep kind of your, your one non negotiable. There are other things that you’ll sacrifice instead. But maybe sleep’s the most important thing to you or maybe your, your nutrition’s the most important thing. And the wearables will help you determine where you’ve got that play and where you don’t. And so making sure at a much younger age that you’re building muscle mass. We get a lot away for a really long time with being skinny fat. So we look little and everybody assumes, we assume that we’re in shape, but we’re not consciously developing the muscle mass. And for women that’s critical because when our hormones turn off and our metabolism slows down for all of the reasons that it does, the only thing that’s going to drive your metabolism in a non estrogen environment are chemicals that made in muscles. And without the muscle mass, your metabolism will stay slow. Without the muscle mass, you’re not going to have the strength to prevent falls. So if you think at 55 you can start to build muscles, it’s a really big ask. Dr. Deb Muth 21:26Yeah, it’s tough. Dr Deb Heald 21:28And testosterone is the hormone that we need to build muscle mass. And through menopause and postmenopausally most of our Testosterone is getting converted to estrogen. So starting at that point, it’s just too late. So once again, let’s go back to the 30 year old and what are you doing on a regular basis to build and maintain muscle? Dr. Deb Muth 21:49Yeah, when you’re in your prime is when we should be looking at these things. We shouldn’t be waiting until our health and our life age is declining to all of a sudden say, okay, now I’ve got to biohack my way back to being 30 at 50 or 60, because A, it’s much harder to do and B, for a lot of women you don’t ever do it correctly and so you’re trying to mimic that time frame, but it’s, it’s a major challenge for sure. Dr Deb Heald 22:15And then back to these kids that we fed plastic from day one. What are their menopause is going to be like? Because the, all that plastic will disrupt their estrogen receptors and we don’t know what impact it’s having on ovaries directly. The stronger that they can be, the more nourished they can be before their menopause starts, the further ahead they’re going to be. So this isn’t, it’s not just really targeting women that are 45 and older. It’s literally all women really need to be taking it into their own hands because the medical system, like I said so far, is not. And I’m not sure when they will. But we don’t have to wait for the medical system. There are things we can do every single day that are going to help us stay in control of our, our health. I can tell you that. Health span. Dr. Deb Muth 23:02Health span, Correct. And I, I see a lot of young people and there is maybe one out of ten of the young people that I see that have normal hormone levels for their age. I start testing hormones on young women and men around 20, unless there’s a need to do it sooner. But I want to see what they are at their peak. And I have men, young men in their 20s and 30s that have a testosterone level of 100 to 300, when they should be closer to 800, 900. I have young women who can’t peak an estrogen above 50 at 20, when in mid cycle when they should be closer to 100, 150, they’re making no progesterone, they’re making minimal to no testosterone for women. And so when we ask what has this environment done to those young women and men that we have, it’s completely destroyed their hormonal function. They are not at peace and then we wonder why they sit around and have no motivation or drive. I have young men in their 20s with no sex drive. They’re just kind of asexual beings. They don’t even look at a woman and get excited. Women don’t look at men and get excited. There’s none of that that’s happening because they’re lacking these hormones that allow them to do that. And then we wonder what is that going to do to them at menopause? Well, what is it doing to them now? You know, it is creating damage. Those hormones are necessary for cognitive function and bone health and cardiovascular health and all of that. And we’re not asking the right questions, I’m afraid. Dr Deb Heald 24:29Yeah. And, and even if we can see that the gonads are producing the hormones, what’s going on on the cellular membrane level with all those pollutants that the cell can’t absorb them? Dr. Deb Muth 24:43Right. Dr Deb Heald 24:43So anyway. What a mess. Dr. Deb Muth 24:45Yeah, it is. Dr Deb Heald 24:45And, and here’s the thing is it boils down to the naturopathic principles. Improve food, how can we improve sleep, how can we help people manage stress more effectively and, and encourage people to be exercising. I mean, this stuff is gold. Yeah. Dr. Deb Muth 25:01And it’s things that you could do very simply. We don’t, you don’t need to build a, you know, ten thousand dollar gym in your basement to do this. There are ways that you can do this very easily for no cost at home. You just need to get the motivation and the drive and understand how to do it. Dr Deb Heald 25:17Yes. And with the resistance bands that are absolutely available everywhere, even if you’re traveling, you can throw a band in your suitcase and do just the tiniest little bit of muscle reinforcement while you’re away. Dr. Deb Muth 25:32It’s so much simpler than we think. We make it very complicated. Dr Deb Heald 25:35But then also the thing that’s missing when you’re doing it at home can be that motivation. So how do we make this important enough that it’s, it is non negotiable for people? They wake up and they do, they woke, woke up a little bit late. So today Maybe they do 10 minutes, not 20, but just be doing something. Right. Dr. Deb Muth 25:54Yeah. You got to get moving it, you know, sitting around on the couch isn’t moving. You know, you have to get up, you have to move. Even if you’re sitting at your desk and you get a little bike thing underneath your desk that you can put into pedal, you know, you’re moving. It’s not weight bearing, but you’re moving. And that weight bearing exercise is so important to Us. Dr Deb Heald 26:17How does this become something that’s sexy? Dr. Deb Muth 26:21Yeah, that’s what we need to make it right. Dr Deb Heald 26:24Yes. Even, even in the realm of food, when people decide to go onto an exclusionary eating plan, so they’re, they’re going to go keto. So excluding anything that is carbohydrate based in their diet, there are a few people healthy enough to do that and they generally can do it healthfully for a short period of time. But to stay on that type of diet for a long time, that’s where I love the wearables. It’s sort of like the same thing when people are vegetarian or vegan, it’s very, very hard. It has to be a very conscious process to stay healthy as a vegetarian or a vegan. Because your liver has so many things to do. It has 500 functions that it carries on at all moments every day. And when you eliminate animal protein, you’re now also asking it to manufacture other protein and amino acid sequences on top of everything else it’s going to do. So when you make a decision like that, what are you going to eliminate from your world to take some of the burden off of your liver so it has the capacity to do extra work and you have to do these negotiations or you just end up being depleted. But the communities that are vegetarian or vegan to a greater degree and keto to a greater degree have support. You can join all sorts of online groups for people that are following these restrictive type of diet. Being an omnivore, which is eating not bread but carbohydrate in the form of vegetables and fruits, and getting some animal protein, some plant based protein, healthy fats, not the processed fats. There’s no support group for being an omnivore. Dr. Deb Muth 28:05No, there’s that. Dr Deb Heald 28:07So it isn’t one that people are going to opt into necessarily. Because who’s going to support you through your healthy eating choices? Dr. Deb Muth 28:15What are some of the biggest advancements you’re seeing right now in whole body healing that actually move the needle for us that just aren’t fancy trends but actually work? Dr Deb Heald 28:25It’s back to that individual monitoring of what’s going on. So for women that want to lose weight and go on a calorie restricted or carbohydrate restricted diet and they are deciding that they’re going to exercise at the same time. If you are in a rested state, when you go to sleep, your body will burn from fat. In the rested state, if you’re in a stressed state, it needs carbohydrate, it needs Instant energy, right? To. To break down fat into a usable fuel. Takes the liver about eight steps to burn carbohydrate. It’s instant. So when you’re stressed, you’ll burn carbs. When you’re resting or relaxed, you’ll burn fat. But if somebody goes to bed in a stressed state, they opened an email that annoyed them. They are wondering why their child came home late again. Whatever. You go to bed in a stress state, you’ll burn carbs all night long. You wake up in the morning already in a stress state. You decide you’re going to exercise in a fasted state because somehow it got imprinted in our head that you’re supposed to be fasting when you exercise to get the best benefit, and you decide to do intervals, which are a huge stress on your body, an intentional stress on your body. You’re already stressed. Stress. How much fat are you going to burn in that process? None. None. Dr. Deb Muth 29:45And you don’t have any carbs left to burn. Dr Deb Heald 29:48Right. So guess what you burn now? Muscle. Dr. Deb Muth 29:50Muscle. Dr Deb Heald 29:51So here we are working out to try and build muscle, but instead we’re breaking muscle down. So if people can use the biometric data to say, I’m in a stress state, and I know that because my heart rate is higher, or I’m using a device that can actually show how much carbon dioxide I’m exhaling. So if you’re exhaling a lot of carbon dioxide, it means you’re burning carbs. You don’t exhale carbon. You don’t need to exhale carbon dioxide if you’re burning fat as your energy store, it’s not a byproduct of fat. So if you’re already in a stress state, you can either change the type of exercise that you want to do today, so doing more of an endurance exercise, or you can eat and then do your concept. Dr. Deb Muth 30:31What. Dr Deb Heald 30:32So that’s where I’m seeing the improvement is when people are actually starting to collect their data and I interpret it for them until they can start to make those. Those correlations themselves. What. What do I need to eat right now? What do I need? What type of exercise do I need to do right now? And in everybody’s day, there is an ideal time for them to eat carbs. But for a great number of women through Perry and postmenopause that eat carbohydrates, in the evening, they get these big sugar spikes or from eating the carbs, blood sugar. And then about the time they’re going to bed, maybe an hour or two after they go to bed, their blood sugar drops and their body thinks, oh my gosh, we’re starving and it goes into a stressed state. So all night long from that point on, they’re breaking down muscle to create carbohydrate energy so that their stress system can be satisfied that they’re not starving to death. So it’s, it’s not that they can’t eat carbs, it’s that eating them in the evening is putting their body into a stressed state. But at lunchtime it might be fine. And it isn’t even eliminating every single simple carbohydrate or every, I’m going to say treat. We are a reward based society, so the treats are a thing. But maybe it means that if you want to have something sweet after a meal, you do that at lunch and your data will tell you, personally, I would eat, I’m going to call it healthy snacks in the evening mostly because I was bored, certainly not because I was in a starvation state and I started paying attention to my own data and I don’t snack in the evening anymore because it throws my sleep completely off track and it puts me into that stressed, burning carbs all night state. And it’s completely contradictory to my health plan going forward. My parents were, my dad was very long lived, he lived to 93. My mom passed at 84. But I have to say I don’t want the last 15 years of life that either of them had. Just. Yeah, at one point I think my mom thought the family vehicle had flashing red lights on the top of it because she was in an ambulance so often. So I don’t want that. And if I’m doing something that on a routine basis, this is confounding my plan for health span, I have to revisit that. I have to say to myself, you said that you’re, you know, maintaining your health is more important than maintaining your length of life. Look at what you’re doing to your body every single time you eat in the evening. Dr. Deb Muth 33:08If you had to choose one data point that really made the difference for people with a wearable or a device that completely changed how you understood menopause and all of this eating pattern, what would it be through the, through the data lens? Dr Deb Heald 33:22Heart rate variability. Yeah. And so that’s. And certain devices, well, a lot of devices measure it. Some of them are more meticulous with what time frame they’re capturing the variation in heart rate. And I guess for the listeners, we should talk about what heart rate variability is. If your heart rate is beating 72 times a minute, which used to be considered the norm. If you’re in a stressed state, if your sympathetic nervous system or your adrenaline nervous system is driving the bus, every single heartbeat in that minute will be the exact same distance between the beats. When you’re in a relaxed state, it still might be beating at 72 times a minute, but one beat might come a little bit earlier, the next one a little bit later, and there’s more variation between the time between the heartbeats. And that shows that you’re in a relaxed or adapting state. When we’re in fight flight, we’ve got one mission and that’s just staying alive. When we’re in that rest digest, it’s like if it’s a little bit slow, it doesn’t matter because I’ll just speed the next one up. And we’ve got the ability to adapt second to second. So if we are measuring heart rate variability in somebody and in it’s low, it means that they’re in that stressed nervous system state more of the time. And it causes you to burn carb more often than fat, even though fat’s a much better energy store. And the byproducts of carbohydrate combustion cause free radical stress to our body oxidation and inflame organ systems. So the more time we can spend not in fighting flight, the more healthy we will be. And so if you’re using some devices, they’re measuring your heart rate variability through a 24 hour period. So when you are in the peak of your stressed state, your heart rate variability will be little. And then when you’re in a relaxed state, it will be more. And on a 24 hour scale, it looks like you’ve got more heart rate variability. Some of the devices narrow it down to measuring your heart rate variability in the first five minutes after you come out of deep sleep. So there’s way less variability in that number. So the number will be lower than a 24 hour measure, but it’s more accurate. And so I like to, I like to narrow it down to that. But if somebody’s using a device that does it the other way, let’s just compare apples with apples. And so if your heart rate variability is improving, it’s improving. Dr. Deb Muth 35:58So that’s awesome. And that’s an easy thing to be able to measure for people. Dr Deb Heald 36:02It’s on most watches that are measuring biometrics and it’s definitely on the rings and the bands and all of the things. So just working to improve that. And if you’ve had your heart rate variability at a certain level. And then today it’s much lower. Literally just do that process in your head. What was different about yesterday? Oh, I lost my job or I ate from a buffet or whatever it is. And then the next time it has that same fall, see if the trigger for it correlated. And it’s literally just teaching us to pay attention to when our body’s in a state of stress because we’re so used to it that we don’t know anymore. The body’s screaming at us, but we’ve just become so numb to the changes to our body that we think it’s normal. Dr. Deb Muth 36:58Right. Because most of us, let’s realistically are walking out around in a State of Stress 24, 7. The only time you’re at quote, unquote rest is when you’re sleeping, if you’re lucky enough to be doing that. But we think we are because we’re not conscious anymore. And we think our body’s resting, but it may not be. Dr Deb Heald 37:17That’s right. So we are in a state of unconsciousness. But if, if we are burning carbohydrate while we’re sleeping, we are not getting into that restorative state, which means your liver is being distracted and isn’t able to do its peak detox at night. Here’s the thing. Our body is supposed to make cholesterol for us between 1am and 4am and if we’re in a stress state, the mechanism that limits the time that the body manufactures cholesterol to those three hours, that mechanism gets turned off. Off. So the body now manufactures cholesterol 24 hours a day. Oops. Dr. Deb Muth 37:53We wonder why it’s always high. Dr Deb Heald 37:55So, and, and it has everything to do with not getting into restorative sleep. So why are we getting into restorative sleep? Dr. Deb Muth 38:02Right. Well, because we’re constantly stressed and we’re not eating properly. Dr Deb Heald 38:06There we go. So we’re back to sleep and food and exercise and stress management. Dr. Deb Muth 38:11Yeah. Is there an easy way for people to. To pull their data out of their devices that they can look at it as a picture so that they can kind of see maybe the last week or the last two weeks and really start to dig in and see what that data means? Dr Deb Heald 38:29Yes. Almost all wearables now have an app attached to them. So when they know where to go to find the data, it will almost always, in an app, pull it up. But what I’m seeing now is almost all the wearables have some type of AI integration where you can literally, on the app, type in, please show Me, my heart rate variability over the last two weeks. And it’ll just populate on the app a graph. What we’re doing with biometric data and the science and the availability of analysis of that data is mind blowing. I think it could be more effective at improving people’s health than anything that we’re going to see happen in a hospital or in a pharmaceutical company’s research lab. Dr. Deb Muth 39:12Yeah, I think AI has a lot of great benefits in the medical world like this. Compiling data, looking at data over a period of time. We all know, you and I both, we’ve done research. You know, how long it takes to comb through the research and to find things and to try to put it all together. And when AI can be used to help us hack that in a shorter period of time, we are going to make new discoveries so much faster that are going to help people in ways that we’ve never seen before. Dr Deb Heald 39:46It’s the perfect indication for AI. And even when I was working with it back in 2017, oh my gosh, it was just barely an embryo back then. And the whole premise behind it was we still need the, the clinical brains, yes, to point out the relevance of the data, but the AI can take care of all of the mundane stuff that none of us like doing anyway, and it can do it instantaneously. And at this point, we still need the clinicians to show where that’s relevant. Dr. Deb Muth 40:19We started using AI this last year to look at our own data. I have data going back almost 25 years of patients that we’ve seen and protocols that we’ve done. And we wanted to see, of all the protocols that we’ve used over the years, which ones actually worked compared to those that didn’t and how much better outcome and how quickly, because we wanted to see, can we make our protocols better and which ones just should we be abandoning that just are not working for the majority of the people. And we started combing our data and it’s been incredible because it’s easy for us, us to, to see the client and think, gosh, this is working, and so I’ll use it on this person and this person and this person. But then you lose sight of those little intricacies of, well, it worked on this person at this age, but it didn’t work on this person who had this or they didn’t have the combination of these two things. And now we’re being able to see all of that so that we can get people better, faster just by simply knowing the data. Dr Deb Heald 41:20Well, and it isn’t Even so much protocols that need to be scrubbed. It’s. If you’ve got somebody on a protocol, there’s real time data to say continue or pause. This isn’t the way it should. That’s my least favorite word in the entire language but should be going, so what’s different about this person or what was different about their yesterday that we’re. We’re not seeing what would encourage us to continue. And, and every single individual has different needs at different times. Even, even twins. Right. With the studies are amazing. And when any difference in their environment they manifest completely differently. So it’s not genetics. Dr. Deb Muth 42:10No. It’s epigenetics. Dr Deb Heald 42:11Right. Dr. Deb Muth 42:11It’s our environment that changes our genetics and that is the difference. Dr Deb Heald 42:17So looking at the genes is one thing, but looking at somebody’s actual response to an intervention in lifetime. This isn’t blood work that’s going to be done every three months. This is, this is what form of exercise should I do right now or should I eat or not eat before I do it. It’s. I think that’s where medical science to me is the most exciting is literally putting the power back into the hands of the human. Dr. Deb Muth 42:46And honestly, from a client perspective, if you don’t learn this and you don’t learn how to hack your day to day stuff, there is nothing that Dr. Heald or myself can really help you with to make you get where you want to go. Like we have the information, we have the knowledge, we can teach you. But you have to be willing to learn this to hack your like life every single day to get to the optimization that you’re looking for. Because trying to depend on somebody like us to tell you what to do every day is unrealistic. It’s just not going to happen. Dr Deb Heald 43:17Agreed. Yeah. It’s almost gamifying your health. But if that’s what it takes, let’s do it. Dr. Deb Muth 43:23Yeah, why not? Why not have some fun with it. Dr Deb Heald 43:25I love waking up and seeing not so much. I can tell by the way I feel how deep my sleep was. My brain’s either foggy or it’s not. Yeah. But I still love looking at the data and then saying, oh, I did do that yesterday. And to me it’s, it’s a game in the morning to open my app and see how yesterday actually manifested in my ability to get rest last night. Dr. Deb Muth 43:53Yeah, it’s so true. I, I did some traveling on Tuesday and we have a little snow. The weather was bad. What normally should have taken me four hours to get somewhere took me seven. There was a crash on the freeway. We got diverted and like the entire drive was completely white knuckled. Right. And so by the time I arrived where I needed to go, it was 12:30 in the morning and I was super stressed. I kind of relaxed a little bit and then I went to bed and I woke up the next, I didn’t sleep well. I was up almost all night. I was up till probably four in the morning before I finally fell asleep. And it took me two days to recover from that stressor and, and I laid low and I rested. It was the holiday, it wasn’t a big deal. But when it takes you that like you have to be conscious, it took me two days to bounce back from that. And we have stressors like that that happen maybe not at that magnitude every single day, but if you’re not paying attention to how long it’s taking you to recover, that is a huge disservice. Because what are we going to do as women? We’re going to put push through. Right. We need to take care of the kids, we need to work, we need to take care of our parents, we need to check on this person, we need to do this, we need to do that and we’re just going to keep pushing in that state of stress, not realizing that that’s the last thing that we should be doing. Dr Deb Heald 45:08And so there will be non negotiables in that when and which generation where our near adult or adult kids still need us and our parents are, are still needing assistance. Maybe it just means don’t do the intense work up to day move, but just pair it back. Or if your partner suggests inviting the neighbors over for appetizers and drinks like not tonight sweetie. Right. Like literally just drawing the line because you said it. Well, we, we will just push through. Yeah. It’s our future health that we’re sacrificing when we do that. And I do not want to spend my last 15 years sick. I do not want to spend my last, last however many 15 minutes in, in a care facility. Right. Dr. Deb Muth 45:54You and me both, we both know how those are. No, that’s a non negotiable for me. Dr Deb Heald 45:59Agreed. And so when, when people are thinking, well, I know it matters but I can pay attention to it later or it costs money to do this and I’d rather not spend that money. Let’s just price out what one month in a nursing home is going to cost. Dr. Deb Muth 46:13Yeah, you’re going to spend it on the front end or the back end. You get to choose how you’re going to do that and what that’s going to look like for you. Dr Deb Heald 46:20So if that’s some wearables and some guidance up front, let’s do it. And my hope is that when we are more aware of what our behaviors do to our physical body, we’ll also start to tune into the physical signs that’s been sending us all the way along. So we don’t have to be dependent on some band on our wrist. But if you eat something that that’s triggering your immune system, you’ll pay attention to the fact your nose is running. You won’t just wipe it and carry on. It’s literally a histamine release unless it’s hot soup. But it’s saying, this is going to inflame you a little bit. Are you okay with that? And when we start to treat our bodies like the temples that they are, we won’t need the wearables. Right? We’ll say, oh, I’m starting to feel tired. So what that means is I’m going to go to bed. I’m not going to turn on a Netflix series. I’m not going to dive into some project for work that I’d like to get off my plate. My body’s asking for rest right now. So let’s do it. Dr. Deb Muth 47:23I love that this has been such a great conversation. How can people find you and work with you if they’re interested? Dr Deb Heald 47:30I agree. This has been an amazing conversation. I hope that we can do it again. I have a website which is is doctorhealed.com r h E-A-L-D.com I’m on Instagram. That’s Dr. Deb healed. And just direct message me and we will see what we can do. Dr. Deb Muth 47:48I love that. Thank you so much for joining me today. Dr Deb Heald 47:51Well, thank you for hosting and it was just an amazing, amazing time on this. Yeah. Friday morning. Dr. Deb Muth 47:58I agree. Thank you. Dr Deb Heald 47:59Okay, take care. Dr. Deb Muth 48:00This is the part of our conversation I hope you sit with. Because if there’s one truth that keeps coming up not just in today’s episode, but across thousands of women’s stories, it’s this. The body isn’t broken. You haven’t failed, and you’re not imagining what you’re feeling. You have just been taught to follow templates instead of trust data, to chase fixes instead of understanding function, and to silence symptoms instead of listening to them. My hope is that today’s conversation gave you permission to stop guessing and start getting curious about your body’s needs and how to thrive in this episode. If it resonated with you. Please take a moment to subscribe, follow and share. It was someone who needs to hear it. It means the world to us and it really helps us get in front of the eyes of more people. You can find let’s Talk Wellness now on YouTube, Spotify and wherever you listen to podcasts. And remember, healing doesn’t just start with another diagnosis. It starts when you finally feel seen and empowered to take your health back. Until next time, I’m Dr. Deb and this is let’s Talk Wellness Now. Dr. Deb Muth 49:08Welcome to let’s Talk Wellness now, where we bring expert insights directly to you. Please note that the views and information shared by our guests are their own and do not necessarily reflect those of let’s Talk Wellness now, its management or our partners. Each affiliate, sponsor and partner is an independent entity with its own perspectives. Today’s content is provided for informational and educational purposes only and should not be considered specific advice, whether financial, medical, or legal. While we strive to present accurate and useful information, we cannot guarantee its completeness or relevance to your unique circumstances. We encourage you to consult with a qualified professional to address your individual needs. Your use of information from this broadcast is entirely at your own risk. By continuing to listen, you agree to indemnify and hold let’s Talk Wellness now and its associates, harmless from any claims or damages arising from the use of this content. We may update this disclaimer at any time and changes will take effect immediately upon posting or broadcast. Thank you for tuning in. We hope you find this episode both insightful and thought provoking. Listener discretion is advised. The post Episode 255 – Advancements in naturopathic medicine and whole-body healing first appeared on Let's Talk Wellness Now.

"Cancel your AG1 subscription... AG1 has no real product substance and is fundamentally an influencer heist."In this episode of Bricks, Bucks & Bytes, Owen, Martin, and Patric dive into the wild world of 24/7 AI agents that can build your startup from bed, manage your Tinder profile, and apparently go rogue with your credit card.What's covered:The Maltbot phenomenon and why AI agents are taking over everyone's timeline (and whether you should let one run your life)Equipment Share's landmark IPO: the first major construction tech exit in years and what their $6B+ valuation means for the industryInside their "Big Short-style" financial engineering with equipment-backed securitiesThe upcoming AEC Fight Night 002 debate: Will AI kill the system of record?Meta's Metaverse abandonment after $75B spent (allegedly)Construction's shrinking labor shortage: what the new numbers really meanRobotics reaching a tipping point with multiple solutions now competing in each tradeHow Panasonic is crashing the price of site scanning technologyA stat that'll make you rethink 3D printing: half of all projects ever happened in 2024Quote of the episode:"I really do not understand the outsourcing of brains. I haven't understood it with social media... and agents is just the next ridiculous iteration of that." — PatricOur Sponsors:Aphex is the multiplayer planning platform where construction teams plan together, stay aligned, and deliver projects faster – check out aphex.coArchdesk -  “The #1 Construction Management Software for Growing Companies - Manage your projects from Tender to Handover” check archdesk.comBuildVision -   streamlining the construction supply chain with a unified platform - www.buildvision.ioChapters00:00 Intro00:54 The Rise of AI in Everyday Life 03:34 IPO Insights and Market Trends 06:32 AI Agents: The Future of Automation 07:38 Cultural Reflections on Technology and Lifestyle 10:04 Debating the Value of AI in Work 13:02 Ethics and Automation: A Double-Edged Sword 15:53 Real-World Applications of AI Agents 17:59 The Future of AI in Business 20:41 Equipment Share IPO: A Case Study 28:08 IPO Timing and Financial Considerations 30:20 Innovative Financial Solutions in Equipment Rental32:22 Global Applicability of Financial Engineering 33:44 Future Growth Strategies for Equipment Rental Companies 35:22 Market Share Insights in the Equipment Rental Industry 36:47 Understanding Voting Rights in IPOs 38:31 Challenges in Connecting with Founders 39:13 Meta's Shift from Metaverse to AI 41:29 Construction Industry Trends and Worker Shortages 43:42 Advancements in Robotics for Construction 46:40 AI's Impact on Robotics Development 48:29 Cost Reduction in Laser Scanning Technology 51:16 3D Printing Trends in Construction

Huge thanks to ICOM for supporting Ham Nation on the Ham Radio Crash Course and their twice monthly giveaways! https://hamnation.icomamerica.com/ New LINK! ICOM Announced the IC-73000MK2 & ID-5200! https://www.youtube.com/live/sLkAw9aTVowHelp Violetta get to Manihiki! https://gofund.me/d20ef2a4Need QSL cards? Consider printing with Amanda! http://www.peakprintingonline.com/index.php/qsl-cards/Gordon West's Study Material can be found here: https://www.gordonwestradioschool.com/Don Wilbanks' Youtube Channel: https://www.youtube.com/channel/UCHXqPB2Ya0yGTtZtfcO5avQ Randy K7AGE: https://www.youtube.com/user/K7AGEDr. Tamitha Skove: https://www.spaceweatherwoman.com/Amateur Radio Newsline: https://www.arnewsline.org/ Want the best HT antenna? Signal Stuff Signal Stick https://signalstuff.com/?ref=622 (This is an affliate link)Looking for the best deal on the Ed Fong J-Pole? https://www.kbcubed.com/DBJ-2H-Amateur-Ham-2m-70cm-Dual-Band-Portable-Rollup-Antenna-by-Ed-Fong-p406009746The Coax I use is ABR Industries (10% off with code: "abr10hrcc"): https://abrind.com/?sld=6I use Ham Radio Deluxe: https://www.hamradiodeluxe.com/aff/2DC45C837DEE2A018A2BCB345A2E3900/index.html?subid=558903You can find some of my favorite radios and gear at GigaParts: https://www.gigaparts.com/nsearch/?lp=JOSHGood Value HTs: HTs: https://www.buytwowayradios.com/?cmid=amsreGRvTmttM0k9&afid=Mkx1eE1uN2M0S1k9&ats=bHNrMHVhZ3lZcjQ9Check out Radioddity ham radio radios and get a discount: Xiegu G90: https://www.radioddity.com/?ref=bkobuwhc Support Ham Radio Crash Course Content Patreon - https://www.patreon.com/hoshnasi 

The 2026 Advanced Crop Advisors Workshop held in Fargo on Tuesday and Wednesday featured alternative weed control options. Noel Anderson is a Technical Advisor to Grand Farm. See omnystudio.com/listener for privacy information.

Our 232st episode with a summary and discussion of last week's big AI news!Recorded on 01/23/2026Hosted by Andrey Kurenkov and Jeremie HarrisFeel free to email us your questions and feedback at contact@lastweekinai.com and/or hello@gladstone.aiRead out our text newsletter and comment on the podcast at https://lastweekin.ai/In this episode:OpenAI announces testing of ads in ChatGPT and introduces child age prediction to enhance safety features, amidst ongoing ethical debates and funding expansions in AI integration with educational tools and business models.China's AI landscape sees significant progress with AI firm Jpu training advanced models on domestic hardware, and strong competitive moves by data centers, highlighting the intense demand in AI manufacturing and infrastructure.Silicon Valley tensions rise as startup Thinking Machines experiences high-profile departures back to OpenAI, reflecting broader industry struggles and rapid shifts in organizational dynamics.AI legislation and safety measures advance with the US Senate's Defiance Act addressing explicit content, and Anthropic updating Claude's constitution to guide ethical AI interactions, while cultural pushbacks from artists signal ongoing debates in intellectual property and AI-generated content.Timestamps:(00:00:10) Intro / Banter(00:02:08) News Preview(00:02:26) Response to listener commentsTools & Apps(00:11:55) OpenAI to test ads in ChatGPT as it burns through billions - Ars Technica(00:18:05) OpenAI is launching age prediction for ChatGPT accounts(00:23:37) Google now offers free SAT practice exams, powered by Gemini | TechCrunch(00:24:57) Baidu's AI Assistant Reaches Milestone of 200 Million Monthly Active Users - WSJApplications & Business(00:26:53) The Drama at Thinking Machines, a New A.I. Start-Up, Is Riveting Silicon Valley - The New York Times(00:31:44) Zhipu AI breaks US chip reliance with first major model trained on Huawei stack | South China Morning Post(00:36:31) Elon Musk's xAI launches world's first Gigawatt AI supercluster to rival OpenAI and Anthropic(00:41:25) Sequoia to invest in Anthropic, breaking VC taboo on backing rivals: FT(00:45:18) Humans&, a 'human-centric' AI startup founded by Anthropic, xAI, Google alums, raised $480M seed round | TechCrunchProjects & Open Source(00:48:51) Black Forest Labs Releases FLUX.2 [klein]: Compact Flow Models for Interactive Visual Intelligence - MarkTechPost(00:50:35) [2601.10611] Molmo2: Open Weights and Data for Vision-Language Models with Video Understanding and Grounding(00:52:53) [2601.10547] HeartMuLa: A Family of Open Sourced Music Foundation Models(00:54:46) [2601.11044] AgencyBench: Benchmarking the Frontiers of Autonomous Agents in 1M-Token Real-World ContextsResearch & Advancements(00:57:05) STEM: Scaling Transformers with Embedding Modules(01:06:22) Reasoning Models Generate Societies of Thought(01:14:21) Why LLMs Aren't Scientists Yet: Lessons from Four Autonomous Research AttemptsPolicy & Safety(01:19:41) Senate passes bill letting victims sue over Grok AI explicit images(01:22:03) Building Production-Ready Probes For Gemini(01:27:32) Anthropic Publishes Claude AI's New Constitution | TIMESynthetic Media & Art(01:34:13) Artists Launch Stealing Isn't Innovation Campaign To Protest Big TechSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this conversation, Marshall and Nick discuss the evolving landscape of the detailing industry, focusing on advancements in technology, tools, and products. They explore the increasing consumer anxiety surrounding weather events, the implications of new products like sprayable PPF and wipe-on clear coats, and the challenges of pricing and consumer understanding in the market. The discussion highlights the need for critical evaluation of industry claims and the practical applications of new technologies.Chapters00:00 Snowpocalypse 2026: A Cultural Shift in Weather Reactions03:12 Advancements in the Detailing Industry: Tools and Technology06:08 Evaluating the Value of Industry Advancements08:51 The Reality of Sprayable PPF: Innovation or Illusion?12:00 Wipe-On Clear Coats: A New Trend or Old Technology?15:02 The Economics of Detailing: Can Advancements Be Profitable?17:55 The Future of Detailing: What Lies Ahead?24:13 The Economics of Luxury Car Care27:04 Imagining the Perfect Car Protection29:57 Market Viability of Advanced Products30:18 The Shift in Car Enthusiast Culture33:52 Challenges with Carbon Fiber Maintenance36:09 Interior Care: Balancing Cleanliness and Protection39:52 Addressing Common Detailing Questions42:42 Restoring Worn Interiors

Fibroid care: how it was, how it's changing, and where it's headed next. In this episode of BackTable OBGYN, hosts Dr. Mark Hoffman and Dr. Amy Park welcome minimally invasive GYN surgeon Dr. Arleen Song to discuss the evolving landscape of fibroid care. --- SYNPOSIS Dr. Song, a veteran in the field with nearly 20 years of experience, shares her journey from Michigan to Duke, current treatments in fibroid management, and the importance of personalized care. The team explores new surgical techniques, the role of medical therapies such as Ella GnRH antagonists, and the importance of patient education. They also address challenges such as access to care, the significance of research funding, and the evolving understanding of fibroid genetics and long-term management. This episode provides a comprehensive overview of the state of fibroid care and the strides being made in this vital aspect of women's health. --- TIMESTAMPS 00:00 - Introduction02:21 - Evolution of Fibroid Treatment05:50 - Advancements in Minimally Invasive Surgery08:47 - Longitudinal Care and Personalized Treatment13:00 - Modern Approaches to Fibroid Treatment21:15 - New Technologies and Procedures27:01 - Preoperative Assessment and Imaging31:15 - Preoperative Counseling and Risk Assessment33:14 - Medications for Fibroid and Endometriosis37:59 - Challenges in Access to Care38:43 - Racial Disparities in Fibroid Research42:35 - The Importance of Specialized Care49:22 - Future Directions in Fibroid Treatment

Stay informed on current events, visit www.NaturalNews.com - Preparing for the Storm (0:00) - Using Noco Genius Products (2:13) - Diesel Generator Maintenance (6:17) - Advancements in Dioxin Testing (8:34) - Lab Testing and Food Science (12:17) - Brightelearn.ai and AI Technology (14:50) - AI and Writing Style (22:28) - DeepSea Model 4 and AI Advancements (39:12) - Decentralized AI and Privacy (58:51) - Supporting AI Development (1:10:22) - Brighteon AI Platform Overview and Accessibility (1:12:51) - Introduction to Peptide Therapy and Personal Transformation (1:25:50) - Benefits and Risks of Peptide Use (1:42:48) - Comparison of Different Peptides (1:43:08) - Challenges and Solutions in Peptide Therapy (1:46:55) - Root Cause Reset Course Overview (1:47:09) - Environmental Toxins and Their Impact on Health (1:54:12) - Legal and Ethical Considerations in Peptide Use (1:54:47) - Conclusion and Call to Action (1:55:16) - Glyphosate and Heavy Metals in Food (1:55:49) - Lab Testing and Health Ranger Store (2:31:01) - Doctor's Lack of Toxicology Knowledge (2:32:16) - Urine Testing and Toxicology Course (2:33:27) - Personal Transformation and Health Advocacy (2:34:26) - Final Thoughts and Contact Information (2:37:23) Watch more independent videos at http://www.brighteon.com/channel/hrreport  ▶️ Support our mission by shopping at the Health Ranger Store - https://www.healthrangerstore.com ▶️ Check out exclusive deals and special offers at https://rangerdeals.com ▶️ Sign up for our newsletter to stay informed: https://www.naturalnews.com/Readerregistration.html Watch more exclusive videos here:

Episode 334 hosts Dr Kourosh Tavakoli (Plastic Surgeon from Sydney, Australia) In this episode we discuss the latest trends and innovations in plastic surgery. We cover the rising popularity of GLP-1 weight loss drugs and the significant impact they are having on surgical trends and procedures. We then do a deep dive into the current preferences in breast aesthetics and the continuing evolution in techniques including as implant technology, lipo filling and the use of mesh for 'internal bra' support. We also cover the rare complications of breast implants known colloquially as 'breast implant illness' and 'breast implant associated cancer'. Our conversation also touches on the challenges faced by Australian surgeons given the stringent marketing regulation changes and the pros and cons of patient education through social media.  00:00 Introduction and Podcast Overview 00:40 Holiday Reflections and Introducing Dr Kourosh Tavakoli 02:29 Trends in Cosmetic Surgery 02:53 Impact of GLP-1 Agonists on Cosmetic Procedures 04:03 Breast Implant Trends and Patient Preferences 28:28 Breast Implant Illness and Patient Education 33:12 Practical Approach to Diagnosing Breast Implant Illness 34:06 Debunking Myths About Injectables and Chronic Symptoms 36:05 Advancements in Breast Surgery Techniques 37:46 Liposuction and Lipo Filling for Breast Enhancement 41:24 The Role of Internal Bras in Breast Surgery 50:22 Regulations and Social Media in Plastic Surgery 59:17 Challenges for New Plastic Surgeons 01:05:28 Conclusion and Final Thoughts ALL IA LINKS & CONTACT INFORMATION

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're delving into the dynamic landscape of scientific breakthroughs, regulatory shifts, and strategic business maneuvers that are shaping the future of healthcare.The pharmaceutical industry is currently abuzz with discussions surrounding Pfizer's leadership, which has taken a firm stance against anti-vaccine narratives, particularly those propagated by figures like Robert F. Kennedy Jr. This critique highlights ongoing tensions between pharmaceutical companies and public health narratives that can significantly impact vaccine distribution and uptake. This situation underscores the crucial role of public trust in the industry's efforts to efficiently manage public health crises and ensure vaccine accessibility.Johnson & Johnson has projected its 2026 revenue to exceed $100 billion, largely driven by the success of its oncology treatment, Darzalex. This strategic focus on cancer therapies not only highlights J&J's commitment to expanding its oncology portfolio but also reflects broader industry trends where targeted cancer therapies are becoming pivotal revenue drivers due to their high efficacy and growing demand.Meanwhile, Takeda is navigating the challenges associated with patent expirations for its depression drug Trintellix. The anticipated patent cliff has led to a reduction of 243 positions within its U.S. neuroscience field force. This scenario emphasizes the ongoing importance of strategic planning around drug lifecycle management as companies strive to sustain revenue streams amidst patent expirations.Curia Global is also undergoing restructuring as it closes its Massachusetts plant, resulting in 81 job cuts. This move aligns with a broader trend in the industry aimed at optimizing operational efficiencies in response to shifting market demands and cost pressures.Advancements in rare disease treatments are making headlines with Intrabio's Aqneursa achieving Phase 3 success for ataxia-telangiectasia and receiving EU approval for Niemann-Pick disease Type C. These milestones underscore the critical role of rare disease research in expanding therapeutic options and highlight the potential for orphan drugs to offer substantial clinical benefits alongside commercial opportunities.In a significant collaboration, GSK has licensed Alteogen's enzyme to develop a subcutaneous form of Jemperli, a promising cancer medication. This partnership exemplifies the industry's focus on enhancing drug delivery technologies to improve patient compliance and therapeutic outcomes.Regulatory developments continue to unfold with notable approvals such as Ionis and Otsuka's hereditary angioedema drug receiving EU approval. Such milestones are indicative of the regulatory momentum that can facilitate market entry and expand access to innovative treatments across different geographies.Novo Nordisk's strategic shift away from cell therapy assets marks another noteworthy development within the industry. By divesting these assets, Novo Nordisk illustrates a broader reevaluation concerning investments in emerging technologies versus more traditional therapeutic areas.Turning our attention to financial strategies, Roche has made headlines with a substantial $2 billion investment in North Carolina aimed at supporting obesity-related drug production. This expansion underscores the critical role of manufacturing infrastructure in meeting rising global demand for innovative therapies—particularly in addressing conditions like obesity.The integration of AI into clinical improvements continues to gain traction in the biotech sector, with reports indicating higher success rates in clinical trials due to enhanced data analytics capabilities. This technological integration represents a paradigm shift in how clinical trials are designed and executedSupport the show

Our 231st episode with a summary and discussion of last week's big AI news!Recorded on 01/16/2026Hosted by Andrey Kurenkov and Jeremie HarrisFeel free to email us your questions and feedback at contact@lastweekinai.com and/or hello@gladstone.aiRead out our text newsletter and comment on the podcast at https://lastweekin.ai/In this episode:Anthropic's new cowork tool integrates Claude code, potentially simplifying multiple computing tasks from editing videos to compiling spreadsheets.Significant funding rounds see Anthropic raising $10B at a valuation of $350B, while XAI raises $20B, underscoring the immense market interest in AI startups.Nvidia faces supply challenges for H200 AI chips due to overwhelming demand from China, despite high costs per unit and its potential impact on U.S. company revenue.Policy debates highlight tensions around U.S. export controls to China, with leaders like Justin Lin from Alibaba and Jake Sullivan, former national security advisor, weighing in on the ramifications for the AI industry's future.Timestamps:(00:00:10) Intro / Banter(00:01:30) News PreviewTools & Apps(00:02:13) Anthropic's new Cowork tool offers Claude Code without the code | TechCrunch(00:09:45) Google's Gemini AI will use what it knows about you from Gmail, Search, and YouTube | The Verge(00:12:45) Google removes some AI health summaries after investigation finds “dangerous” flaws - Ars Technica(00:16:29) Gmail is getting a Gemini AI overhaul(00:18:12) Slackbot is an AI agent now | TechCrunchApplications & Business(00:20:11) Anthropic Raising $10 Billion at $350 Billion Value(00:22:25) Elon Musk xAI raises $20 billion from Nvidia, Cisco, investors(00:24:47) NVIDIA Needs a Supply Chain ‘Miracle' From TSMC as China's H200 AI Chip Orders Overwhelm Supply, Triggering a Bottleneck(00:29:26) OpenAI signs deal, worth $10B, for compute from Cerebras | TechCrunch(00:31:49) CoreWeave in focus as it amends credit agreement(00:34:30) LMArena lands $1.7B valuation four months after launching its product | TechCrunchProjects & Open Source(00:35:54) Nemotron-Cascade: Scaling Cascaded Reinforcement Learning for General-Purpose Reasoning Models(00:43:15) mHC: Manifold-Constrained Hyper-Connections(00:49:53) IQuest_Coder_Technical_Report(00:54:58) TII Abu-Dhabi Released Falcon H1R-7B: A New Reasoning Model Outperforming Others in Math and Coding with only 7B Params with 256k Context Window - MarkTechPostResearch & Advancements(01:01:42) Deep Delta Learning(01:07:47) Recursive Language Models(01:13:39) Conditional memory via scalable lookup(01:18:54) Extending the Context of Pretrained LLMs by Dropping their Positional EmbeddingsPolicy & Safety(01:26:06) Constitutional Classifiers++: Efficient Production-Grade Defenses against Universal Jailbreaks(01:31:00) Nvidia CEO says purchase orders, not formal declaration, will signal Chinese approval of H200(01:32:24) China AI Leaders Warn of Widening Gap With US After $1B IPO Week(01:37:25) Jake Sullivan is furious that Trump removed Biden's AI chip export controls | The VergeSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

- Weekend Updates and Personal Health Routine (0:00) - Vibe Coding and Technical Knowledge (3:59) - Challenges with AI and Robots (12:07) - Gold and Silver Market Analysis (24:13) - Trump's Tariffs and Geopolitical Tensions (33:25) - Domestic Tensions and Military Deployment (1:00:21) - Depopulation Agenda and AI Advancements (1:16:57) - Advancements in Robotics and AI (1:23:36) - Geopolitical Tensions and Nuclear Threats (1:24:42) - Election Integrity and Depopulation Goals (1:26:59) - Historical Precedents and Government Actions (1:30:32) - Deals with Maduro and Russia (1:33:05) - Political Benefits and Economic Impact (1:37:18) - Conclusion and Call to Action (1:41:01) For more updates, visit: http://www.brighteon.com/channel/hrreport NaturalNews videos would not be possible without you, as always we remain passionately dedicated to our mission of educating people all over the world on the subject of natural healing remedies and personal liberty (food freedom, medical freedom, the freedom of speech, etc.). Together, we're helping create a better world, with more honest food labeling, reduced chemical contamination, the avoidance of toxic heavy metals and vastly increased scientific transparency. ▶️ Every dollar you spend at the Health Ranger Store goes toward helping us achieve important science and content goals for humanity: https://www.healthrangerstore.com/ ▶️ Sign Up For Our Newsletter: https://www.naturalnews.com/Readerregistration.html ▶️ Brighteon: https://www.brighteon.com/channels/hrreport ▶️ Join Our Social Network: https://brighteon.social/@HealthRanger ▶️ Check In Stock Products at: https://PrepWithMike.com

Host: Mindy McCulley, MS Family and Consumer Sciences Extension Specialist for Instructional Support, University of Kentucky  Guest: Dr. Jessica Moss, MD Assistant Professor of Internal Medicine, Medical Oncology, University of Kentucky Markey Cancer Center Cancer Conversations Episode 71 Welcome to Cancer Conversations on Talking FACS with host Mindy McCulley and guest Dr. Jessica Moss, assistant professor of internal medicine in the division of Medical Oncology at the Markey Cancer Center. In this episode Dr. Moss reviews recent advances in breast cancer care, including the incorporation of immunotherapy for triple-negative disease and new targeted therapies for stage IV patients. Topics include how breast cancer subtypes affect treatment and prognosis; the importance of genetic counseling and testing—especially for men, young patients, and those with triple-negative tumors; common risk factors such as obesity, alcohol use, and reproductive history; and warning signs that warrant medical attention. Dr. Moss also discusses how many patients with advanced disease are living longer with improved, less-toxic options. Key takeaways: breast cancer is not one disease, screening and awareness matter, genetic evaluation can guide care, and recent therapies are creating more personalized, hopeful outcomes.  Connect with the UK Markey Center Online Markey Cancer Center On Facebook @UKMarkey On X @UKMarkey

Who should consider fertility preservation, when is the right time, and what are the risks? In this episode of BackTable OBGYN, Dr. Amy Park interviews Dr. Mindy Christianson, the section head of Reproductive Endocrinology and Infertility at the Cleveland Clinic, who shares how fertility preservation is evolving for patients planning families and those facing fertility-impacting treatments. --- SYNPOSIS Dr. Christianson discusses her journey into the field of fertility preservation, inspired by an early encounter with a breast cancer patient. The conversation covers various aspects of fertility preservation, including the preservation of eggs, embryos, ovarian and testicular tissue, and planned fertility preservation. Dr. Christianson elaborates on the protocols, patient demographics, and the evolving collaboration between oncology and reproductive endocrinology. The discussion also highlights technologies like ovarian tissue transplantation and in vitro maturation, as well as practical tips for healthcare providers on improving patient access to fertility preservation services. --- TIMESTAMPS 00:00 - Introduction03:34 - Understanding Fertility Preservation07:56 - Consultation Process for Fertility Preservation17:36 - Advancements in Egg Freezing Technology25:55 - Egg Freezing Recommendations26:34 - Collaboration Between Oncology and REI26:52 - Pediatric Oncology and Fertility Preservation28:58 - Ovarian Tissue Transplantation33:17 - Uterine Transposition Surgery40:05 - Gene Editing and Fertility Preservation43:01 - Financial and Emotional Aspects of Fertility Preservation48:02 - Practical Advice for OBGYNs51:12 - Resources and Final Thoughts --- RESOURCES Livestrong Fertilityhttps://livestrong.org/how-we-help/livestrong-fertility/ Resolve: The National Infertility Associationhttps://resolve.org/ Society for Assisted Reproductive Technologyhttps://www.sart.org/ American Society for Reproductive Medicinehttps://www.asrm.org/

Guest: Jason Auerbach (Bloody Tooth Guy) https://bloodytoothguy.com/   Host: Serv Wahan https://www.drwahan.com/   keywords   oral surgery, social media, dentistry, patient care, dental education, sedation techniques, corporate dentistry, private practice, dental instruments, dental technology, bloody tooth guy, Jason Auerbach, Dr. Wahan, Serv Wahan, Max surgical specialty management, riverside oral surgery, om3surgery, Seattle oral surgeon, new jersey oral surgeon     summary   In this engaging conversation, Serv Wahan MD, DMD, and Jason Auerbach, known as Bloody Tooth Guy, delve into the evolution of social media in dentistry, the challenges posed by algorithms and censorship, and the importance of documentation for dental professionals. They discuss teaching methodologies, ergonomics in practice, and the role of technology in modern dentistry. Auerbach shares his journey to becoming a dentist, the shift from private practice to corporate dentistry, and the evolution of sedation techniques. The conversation concludes with personal insights and reflections on the future of dentistry.     takeaways Social media has transformed how dental professionals share knowledge. Documentation is crucial for self-assessment and improvement in dentistry. Teaching is a vital part of the dental profession, enhancing learning for all. Ergonomics and patient positioning are essential for long-term health in practice. The right instruments can significantly impact surgical outcomes. Technology, like CBCT, has revolutionized dental procedures. The journey to becoming a dentist is often influenced by key individuals. Corporate dentistry is on the rise, affecting private practices. Sedation techniques have evolved, improving patient care. Oral maxillofacial surgery is a rewarding specialty that can inspire future generations.   titles The Rise of Bloody Tooth Guy Navigating Social Media in Dentistry   Sound Bites "I started Bloody Tooth Guy February 20th." "People love to see it, so I'm happy to do it." "A bite block is 101."   Chapters 00:00 Introduction to Bloody Tooth Guy 03:03 The Evolution of Social Media in Dentistry 06:00 The Importance of Documentation in Dental Practice 09:04 Teaching and Learning in Dentistry 12:00 Ergonomics and Patient Positioning 15:03 Instruments and Techniques for Extractions 17:53 Personal Journey to Dentistry 28:55 Early Days in Dentistry 34:41 Advancements in Imaging Technology 39:50 Evolution of Sedation Practices 46:45 The Shift Towards Corporate Dentistry 52:25 The Future of Private Practice 56:24 Reflections on Oral Surgery and Music

Have you ever thought about what it means to be anonymous?  Have you considered what it means that you can walk down the street or go to the grocery store or out to dinner without someone you've never met knowing your name, everything you've posted online, or your political leanings? Or when you go on a first date with someone, they'd walk in knowing your dating history, your political affiliations, your credit score or what groceries you buy? Advancements in facial recognition and a secretive startup could end privacy as we know it.  In this two-part conversation, New York Times Tech Reporter Kashmir Hill joins host Ron Steslow to discuss privacy, anonymity, facial recognition software and her book Your Face Belongs to Us: A Secretive Startup's Quest to End Privacy as We Know It. In part 1: (01:43 ) Ron and Kashmir discuss anonymity and privacy and the erosion of both in our daily lives  (00:00 ) Balancing convenience and privacy  (11:00) The origins of ClearviewAI  (13:30) Genetic determinism in the development of facial recognition  (18:20) Kashmir dives deep into the history of facial recognition software and how it developed.  (22:37) How Facebook crowdsourced training facial recognition technology (25:00) How much privacy should we have and who should be able to use facial recognition software?  Read Your Face Belongs to Us: https://bit.ly/49qsbQm Follow Ron and Kashmir  on X (formerly Twitter): https://twitter.com/RonSteslow https://twitter.com/kashhill Email your questions and thoughts to podcast@politicology.com or leave us a voicemail at ‪(202) 455-4558‬. Learn more about your ad choices. Visit megaphone.fm/adchoices

Have you ever thought about what it means to be anonymous?  Have you considered what it means that you can walk down the street or go to the grocery store or out to dinner without someone you've never met knowing your name, everything you've posted online, or your political leanings? Or when you go on a first date with someone, they'd walk in knowing your dating history, your political affiliations, your credit score or what groceries you buy? Advancements in facial recognition and a secretive startup could end privacy as we know it.  In this two-part conversation, New York Times Tech Reporter Kashmir Hill joins host Ron Steslow to discuss privacy, anonymity, facial recognition software and her book Your Face Belongs to Us: A Secretive Startup's Quest to End Privacy as We Know It. In part 2: (01:40) “Technical sweetness” and the lack of ethical considerations by the people building these new technologies  (12:30) Privacy laws in the U.S. and Europe  (15:24) The trend of law enforcement agencies skirting constitutional protections by buying information from private companies. (27:20) Balancing security and privacy in the age of ubiquitous surveillance (30:50) What the future of privacy might look like  Read Your Face Belongs to Us: https://bit.ly/49qsbQm Follow Ron and Kashmir  on X (formerly Twitter): https://twitter.com/RonSteslow https://twitter.com/kashhill Email your questions and thoughts to podcast@politicology.com or leave us a voicemail at ‪(202) 455-4558‬. Learn more about your ad choices. Visit megaphone.fm/adchoices